Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
REGULATION OF CELL PROLIFERATION |
175 |
1496 |
5.021e-69 |
2.336e-65 |
2 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
191 |
1929 |
4.896e-64 |
1.139e-60 |
3 |
REGULATION OF CELL DEATH |
165 |
1472 |
7.327e-62 |
1.136e-58 |
4 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
181 |
1848 |
2.025e-59 |
2.356e-56 |
5 |
IMMUNE SYSTEM PROCESS |
185 |
1984 |
1.427e-57 |
1.328e-54 |
6 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
155 |
1395 |
3.64e-57 |
2.823e-54 |
7 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
151 |
1381 |
1.311e-54 |
8.712e-52 |
8 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
170 |
1805 |
7.64e-53 |
4.444e-50 |
9 |
POSITIVE REGULATION OF GENE EXPRESSION |
166 |
1733 |
1.855e-52 |
9.589e-50 |
10 |
RESPONSE TO ENDOGENOUS STIMULUS |
151 |
1450 |
7.852e-52 |
3.654e-49 |
11 |
NEGATIVE REGULATION OF CELL DEATH |
118 |
872 |
1.539e-51 |
6.509e-49 |
12 |
REGULATION OF CELL DIFFERENTIATION |
150 |
1492 |
1.739e-49 |
6.741e-47 |
13 |
RESPONSE TO EXTERNAL STIMULUS |
165 |
1821 |
9.16e-49 |
3.279e-46 |
14 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
157 |
1672 |
3.996e-48 |
1.328e-45 |
15 |
LOCOMOTION |
128 |
1114 |
5.144e-48 |
1.596e-45 |
16 |
RESPONSE TO LIPID |
113 |
888 |
1.684e-46 |
4.896e-44 |
17 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
125 |
1142 |
1.633e-44 |
4.469e-42 |
18 |
POSITIVE REGULATION OF CELL COMMUNICATION |
144 |
1532 |
9.025e-44 |
2.333e-41 |
19 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
104 |
799 |
1.497e-43 |
3.666e-41 |
20 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
130 |
1275 |
5.411e-43 |
1.259e-40 |
21 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
110 |
917 |
1.088e-42 |
2.41e-40 |
22 |
REGULATION OF RESPONSE TO STRESS |
139 |
1468 |
1.791e-42 |
3.661e-40 |
23 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
154 |
1784 |
1.81e-42 |
3.661e-40 |
24 |
REGULATION OF IMMUNE SYSTEM PROCESS |
135 |
1403 |
6.309e-42 |
1.223e-39 |
25 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
139 |
1492 |
1.159e-41 |
2.156e-39 |
26 |
POSITIVE REGULATION OF CELL PROLIFERATION |
102 |
814 |
3.6e-41 |
6.443e-39 |
27 |
CELL MOTILITY |
103 |
835 |
5.796e-41 |
9.348e-39 |
28 |
LOCALIZATION OF CELL |
103 |
835 |
5.796e-41 |
9.348e-39 |
29 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
144 |
1618 |
5.826e-41 |
9.348e-39 |
30 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
105 |
876 |
1.242e-40 |
1.927e-38 |
31 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
145 |
1656 |
1.928e-40 |
2.894e-38 |
32 |
TISSUE DEVELOPMENT |
138 |
1518 |
3.963e-40 |
5.762e-38 |
33 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
147 |
1710 |
4.133e-40 |
5.827e-38 |
34 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
97 |
771 |
3.105e-39 |
4.249e-37 |
35 |
POSITIVE REGULATION OF LOCOMOTION |
73 |
420 |
6.842e-39 |
9.095e-37 |
36 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
146 |
1791 |
3.985e-37 |
5.15e-35 |
37 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
109 |
1036 |
6.608e-37 |
8.092e-35 |
38 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
109 |
1036 |
6.608e-37 |
8.092e-35 |
39 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
97 |
823 |
8.329e-37 |
9.937e-35 |
40 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
107 |
1004 |
1.049e-36 |
1.221e-34 |
41 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
105 |
983 |
4.45e-36 |
5.05e-34 |
42 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
124 |
1360 |
7.14e-36 |
7.91e-34 |
43 |
IMMUNE SYSTEM DEVELOPMENT |
81 |
582 |
7.693e-36 |
8.325e-34 |
44 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
112 |
1135 |
2.365e-35 |
2.501e-33 |
45 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
105 |
1008 |
4.158e-35 |
4.299e-33 |
46 |
IMMUNE RESPONSE |
109 |
1100 |
1.596e-34 |
1.615e-32 |
47 |
RESPONSE TO ABIOTIC STIMULUS |
105 |
1024 |
1.672e-34 |
1.656e-32 |
48 |
REGULATION OF CELL ADHESION |
82 |
629 |
3.506e-34 |
3.399e-32 |
49 |
DEFENSE RESPONSE |
115 |
1231 |
4.261e-34 |
4.046e-32 |
50 |
RESPONSE TO HORMONE |
97 |
893 |
7.778e-34 |
7.097e-32 |
51 |
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN |
60 |
321 |
7.644e-34 |
7.097e-32 |
52 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
82 |
643 |
1.758e-33 |
1.573e-31 |
53 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
95 |
867 |
2.003e-33 |
1.758e-31 |
54 |
CELL ACTIVATION |
77 |
568 |
2.935e-33 |
2.529e-31 |
55 |
INFLAMMATORY RESPONSE |
69 |
454 |
5.987e-33 |
5.065e-31 |
56 |
RESPONSE TO WOUNDING |
76 |
563 |
1.065e-32 |
8.848e-31 |
57 |
RESPONSE TO CYTOKINE |
85 |
714 |
1.761e-32 |
1.437e-30 |
58 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
110 |
1192 |
4.61e-32 |
3.698e-30 |
59 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
88 |
788 |
1.57e-31 |
1.218e-29 |
60 |
CIRCULATORY SYSTEM DEVELOPMENT |
88 |
788 |
1.57e-31 |
1.218e-29 |
61 |
RESPONSE TO BIOTIC STIMULUS |
93 |
886 |
3.117e-31 |
2.378e-29 |
62 |
CELL DEATH |
99 |
1001 |
3.613e-31 |
2.711e-29 |
63 |
NEGATIVE REGULATION OF GENE EXPRESSION |
122 |
1493 |
1.219e-30 |
9.007e-29 |
64 |
POSITIVE REGULATION OF CELL DEATH |
76 |
605 |
1.413e-30 |
1.028e-28 |
65 |
WOUND HEALING |
67 |
470 |
2.79e-30 |
1.997e-28 |
66 |
REGULATION OF CYTOKINE PRODUCTION |
73 |
563 |
2.913e-30 |
2.054e-28 |
67 |
RESPONSE TO NITROGEN COMPOUND |
89 |
859 |
1.93e-29 |
1.34e-27 |
68 |
ORGAN MORPHOGENESIS |
88 |
841 |
2.021e-29 |
1.383e-27 |
69 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
121 |
1518 |
2.303e-29 |
1.553e-27 |
70 |
LEUKOCYTE MIGRATION |
50 |
259 |
5.339e-29 |
3.549e-27 |
71 |
RESPONSE TO BACTERIUM |
69 |
528 |
8.02e-29 |
5.256e-27 |
72 |
REGULATION OF TRANSPORT |
132 |
1804 |
1.617e-28 |
1.045e-26 |
73 |
CELLULAR RESPONSE TO LIPID |
64 |
457 |
1.721e-28 |
1.097e-26 |
74 |
LEUKOCYTE ACTIVATION |
61 |
414 |
2.08e-28 |
1.308e-26 |
75 |
LEUKOCYTE DIFFERENTIATION |
52 |
292 |
2.383e-28 |
1.478e-26 |
76 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
84 |
801 |
3.903e-28 |
2.389e-26 |
77 |
REGULATION OF CELL DEVELOPMENT |
85 |
836 |
1.605e-27 |
9.696e-26 |
78 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
94 |
1021 |
3.585e-27 |
2.138e-25 |
79 |
EPITHELIUM DEVELOPMENT |
90 |
945 |
4.609e-27 |
2.715e-25 |
80 |
VASCULATURE DEVELOPMENT |
63 |
469 |
5.062e-27 |
2.944e-25 |
81 |
LYMPHOCYTE ACTIVATION |
54 |
342 |
9.993e-27 |
5.74e-25 |
82 |
REGULATION OF MAPK CASCADE |
74 |
660 |
1.345e-26 |
7.634e-25 |
83 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
51 |
304 |
1.495e-26 |
8.378e-25 |
84 |
RESPONSE TO STEROID HORMONE |
64 |
497 |
2.143e-26 |
1.187e-24 |
85 |
INTRACELLULAR SIGNAL TRANSDUCTION |
118 |
1572 |
2.913e-26 |
1.595e-24 |
86 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
87 |
926 |
9.843e-26 |
5.325e-24 |
87 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
98 |
1152 |
1.081e-25 |
5.783e-24 |
88 |
REGULATION OF KINASE ACTIVITY |
79 |
776 |
1.321e-25 |
6.983e-24 |
89 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
77 |
740 |
1.448e-25 |
7.572e-24 |
90 |
BIOLOGICAL ADHESION |
92 |
1032 |
1.481e-25 |
7.659e-24 |
91 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
114 |
1517 |
2.296e-25 |
1.174e-23 |
92 |
SINGLE ORGANISM CELL ADHESION |
60 |
459 |
3.984e-25 |
2.015e-23 |
93 |
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
42 |
213 |
6.888e-25 |
3.446e-23 |
94 |
TISSUE MORPHOGENESIS |
64 |
533 |
1.092e-24 |
5.404e-23 |
95 |
REGULATION OF PEPTIDASE ACTIVITY |
55 |
392 |
1.316e-24 |
6.444e-23 |
96 |
CELLULAR RESPONSE TO CYTOKINE STIMULUS |
68 |
606 |
1.752e-24 |
8.491e-23 |
97 |
CELLULAR RESPONSE TO BIOTIC STIMULUS |
37 |
163 |
2.491e-24 |
1.195e-22 |
98 |
POSITIVE REGULATION OF TRANSPORT |
85 |
936 |
3.932e-24 |
1.867e-22 |
99 |
REGULATION OF HYDROLASE ACTIVITY |
103 |
1327 |
6.681e-24 |
3.14e-22 |
100 |
REGULATION OF TRANSFERASE ACTIVITY |
85 |
946 |
8.053e-24 |
3.747e-22 |
101 |
RESPONSE TO ALCOHOL |
52 |
362 |
8.62e-24 |
3.971e-22 |
102 |
REGULATION OF CELL CELL ADHESION |
53 |
380 |
1.289e-23 |
5.879e-22 |
103 |
RESPONSE TO GROWTH FACTOR |
59 |
475 |
1.461e-23 |
6.601e-22 |
104 |
LEUKOCYTE CELL CELL ADHESION |
44 |
255 |
1.519e-23 |
6.796e-22 |
105 |
REGULATION OF DEFENSE RESPONSE |
75 |
759 |
1.623e-23 |
7.193e-22 |
106 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
91 |
1087 |
2.482e-23 |
1.09e-21 |
107 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
58 |
465 |
2.887e-23 |
1.255e-21 |
108 |
NEUROGENESIS |
105 |
1402 |
3.632e-23 |
1.565e-21 |
109 |
POSITIVE REGULATION OF PEPTIDASE ACTIVITY |
35 |
154 |
4.275e-23 |
1.825e-21 |
110 |
BLOOD VESSEL MORPHOGENESIS |
51 |
364 |
7.566e-23 |
3.2e-21 |
111 |
GLAND DEVELOPMENT |
53 |
395 |
8.171e-23 |
3.425e-21 |
112 |
REGULATION OF RESPONSE TO WOUNDING |
54 |
413 |
1.092e-22 |
4.535e-21 |
113 |
PROTEIN PHOSPHORYLATION |
83 |
944 |
1.214e-22 |
5e-21 |
114 |
RESPONSE TO INORGANIC SUBSTANCE |
58 |
479 |
1.297e-22 |
5.294e-21 |
115 |
MORPHOGENESIS OF AN EPITHELIUM |
53 |
400 |
1.483e-22 |
5.998e-21 |
116 |
TAXIS |
57 |
464 |
1.512e-22 |
6.065e-21 |
117 |
HOMEOSTATIC PROCESS |
101 |
1337 |
1.545e-22 |
6.146e-21 |
118 |
REGULATION OF CELL ACTIVATION |
58 |
484 |
2.188e-22 |
8.627e-21 |
119 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
83 |
957 |
2.95e-22 |
1.154e-20 |
120 |
POSITIVE REGULATION OF CELL ADHESION |
51 |
376 |
3.362e-22 |
1.303e-20 |
121 |
CELL DEVELOPMENT |
104 |
1426 |
4.653e-22 |
1.789e-20 |
122 |
AGING |
43 |
264 |
5.197e-22 |
1.982e-20 |
123 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
69 |
689 |
5.471e-22 |
2.07e-20 |
124 |
PHOSPHORYLATION |
95 |
1228 |
6.708e-22 |
2.517e-20 |
125 |
REGULATION OF PROTEIN LOCALIZATION |
82 |
950 |
7.416e-22 |
2.761e-20 |
126 |
REGULATION OF CELLULAR LOCALIZATION |
97 |
1277 |
8.514e-22 |
3.144e-20 |
127 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
58 |
505 |
1.824e-21 |
6.681e-20 |
128 |
REGULATION OF GROWTH |
65 |
633 |
2.529e-21 |
9.193e-20 |
129 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
49 |
363 |
2.845e-21 |
1.026e-19 |
130 |
REGULATION OF PROTEOLYSIS |
69 |
711 |
3.201e-21 |
1.146e-19 |
131 |
RESPONSE TO DRUG |
53 |
431 |
4.858e-21 |
1.725e-19 |
132 |
REGULATION OF IMMUNE RESPONSE |
76 |
858 |
6.174e-21 |
2.176e-19 |
133 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
49 |
370 |
6.562e-21 |
2.296e-19 |
134 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
63 |
609 |
7.481e-21 |
2.598e-19 |
135 |
POSITIVE REGULATION OF MAPK CASCADE |
55 |
470 |
8.887e-21 |
3.063e-19 |
136 |
LYMPHOCYTE DIFFERENTIATION |
37 |
209 |
2.292e-20 |
7.841e-19 |
137 |
TUBE DEVELOPMENT |
59 |
552 |
2.884e-20 |
9.795e-19 |
138 |
POSITIVE REGULATION OF KINASE ACTIVITY |
55 |
482 |
2.911e-20 |
9.816e-19 |
139 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
44 |
307 |
3.097e-20 |
1.037e-18 |
140 |
CELL CELL ADHESION |
62 |
608 |
3.264e-20 |
1.085e-18 |
141 |
SKELETAL SYSTEM DEVELOPMENT |
53 |
455 |
5.823e-20 |
1.921e-18 |
142 |
INNATE IMMUNE RESPONSE |
62 |
619 |
8.117e-20 |
2.66e-18 |
143 |
EMBRYO DEVELOPMENT |
75 |
894 |
2.713e-19 |
8.829e-18 |
144 |
REPRODUCTION |
93 |
1297 |
3.45e-19 |
1.115e-17 |
145 |
CELLULAR RESPONSE TO STRESS |
104 |
1565 |
4.521e-19 |
1.451e-17 |
146 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
41 |
285 |
5.461e-19 |
1.74e-17 |
147 |
REGULATION OF OSSIFICATION |
33 |
178 |
6.235e-19 |
1.974e-17 |
148 |
CELL PROLIFERATION |
63 |
672 |
1.152e-18 |
3.621e-17 |
149 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
52 |
470 |
1.299e-18 |
4.056e-17 |
150 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
60 |
616 |
1.311e-18 |
4.065e-17 |
151 |
REGULATION OF NEURON DEATH |
38 |
252 |
2.153e-18 |
6.634e-17 |
152 |
RESPONSE TO OXYGEN LEVELS |
42 |
311 |
2.192e-18 |
6.666e-17 |
153 |
POSITIVE REGULATION OF CELL ACTIVATION |
42 |
311 |
2.192e-18 |
6.666e-17 |
154 |
REGULATION OF CYTOKINE SECRETION |
30 |
149 |
2.229e-18 |
6.734e-17 |
155 |
HEART DEVELOPMENT |
51 |
466 |
4.533e-18 |
1.361e-16 |
156 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
63 |
691 |
4.635e-18 |
1.383e-16 |
157 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
81 |
1079 |
6.874e-18 |
2.037e-16 |
158 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
73 |
905 |
7.607e-18 |
2.24e-16 |
159 |
REGULATION OF CELL CYCLE |
75 |
949 |
7.991e-18 |
2.339e-16 |
160 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
47 |
404 |
8.722e-18 |
2.536e-16 |
161 |
ANGIOGENESIS |
40 |
293 |
9.889e-18 |
2.858e-16 |
162 |
ZYMOGEN ACTIVATION |
26 |
112 |
1.015e-17 |
2.915e-16 |
163 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
47 |
408 |
1.295e-17 |
3.697e-16 |
164 |
OSSIFICATION |
37 |
251 |
1.322e-17 |
3.752e-16 |
165 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
40 |
296 |
1.424e-17 |
4.016e-16 |
166 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
55 |
552 |
1.452e-17 |
4.071e-16 |
167 |
RESPONSE TO MECHANICAL STIMULUS |
34 |
210 |
1.474e-17 |
4.106e-16 |
168 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
65 |
750 |
1.701e-17 |
4.711e-16 |
169 |
POSITIVE REGULATION OF PROTEOLYSIS |
44 |
363 |
2.16e-17 |
5.946e-16 |
170 |
ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
24 |
95 |
2.262e-17 |
6.192e-16 |
171 |
RESPONSE TO METAL ION |
42 |
333 |
2.782e-17 |
7.569e-16 |
172 |
RESPONSE TO OXIDATIVE STRESS |
43 |
352 |
3.795e-17 |
1.027e-15 |
173 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
29 |
152 |
3.859e-17 |
1.038e-15 |
174 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
116 |
1977 |
3.885e-17 |
1.039e-15 |
175 |
CHEMICAL HOMEOSTASIS |
70 |
874 |
5.696e-17 |
1.514e-15 |
176 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
30 |
167 |
6.319e-17 |
1.671e-15 |
177 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
51 |
498 |
7.534e-17 |
1.98e-15 |
178 |
REGULATION OF NEURON DIFFERENTIATION |
54 |
554 |
7.63e-17 |
1.995e-15 |
179 |
REGULATION OF HEMOPOIESIS |
40 |
314 |
1.154e-16 |
3e-15 |
180 |
T CELL DIFFERENTIATION |
26 |
123 |
1.203e-16 |
3.11e-15 |
181 |
POSITIVE REGULATION OF DEFENSE RESPONSE |
43 |
364 |
1.317e-16 |
3.385e-15 |
182 |
REGULATION OF SECRETION |
61 |
699 |
1.324e-16 |
3.386e-15 |
183 |
REGULATION OF BODY FLUID LEVELS |
51 |
506 |
1.464e-16 |
3.723e-15 |
184 |
CYTOKINE MEDIATED SIGNALING PATHWAY |
48 |
452 |
1.535e-16 |
3.882e-15 |
185 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
56 |
602 |
1.584e-16 |
3.983e-15 |
186 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
33 |
213 |
1.728e-16 |
4.324e-15 |
187 |
REGENERATION |
29 |
161 |
1.95e-16 |
4.851e-15 |
188 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
47 |
437 |
1.968e-16 |
4.87e-15 |
189 |
RESPONSE TO ACID CHEMICAL |
40 |
319 |
2.007e-16 |
4.916e-15 |
190 |
REGULATION OF MAP KINASE ACTIVITY |
40 |
319 |
2.007e-16 |
4.916e-15 |
191 |
POSITIVE REGULATION OF CELL CELL ADHESION |
35 |
243 |
2.138e-16 |
5.209e-15 |
192 |
GLIOGENESIS |
30 |
175 |
2.423e-16 |
5.873e-15 |
193 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
51 |
514 |
2.806e-16 |
6.766e-15 |
194 |
REGULATION OF INFLAMMATORY RESPONSE |
38 |
294 |
4.234e-16 |
1.016e-14 |
195 |
REGULATION OF NEURON APOPTOTIC PROCESS |
31 |
192 |
4.401e-16 |
1.05e-14 |
196 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
26 |
131 |
6.145e-16 |
1.459e-14 |
197 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
61 |
724 |
6.866e-16 |
1.622e-14 |
198 |
REGULATION OF PROTEIN SECRETION |
43 |
389 |
1.49e-15 |
3.502e-14 |
199 |
REGULATION OF LEUKOCYTE MIGRATION |
27 |
149 |
1.85e-15 |
4.325e-14 |
200 |
CELL CHEMOTAXIS |
28 |
162 |
1.967e-15 |
4.577e-14 |
201 |
REGULATION OF HOMEOSTATIC PROCESS |
46 |
447 |
2.24e-15 |
5.185e-14 |
202 |
RESPONSE TO ESTROGEN |
32 |
218 |
2.455e-15 |
5.654e-14 |
203 |
REGULATION OF INTRACELLULAR TRANSPORT |
55 |
621 |
2.504e-15 |
5.74e-14 |
204 |
POSITIVE REGULATION OF IMMUNE RESPONSE |
52 |
563 |
2.766e-15 |
6.309e-14 |
205 |
MUSCLE STRUCTURE DEVELOPMENT |
45 |
432 |
2.924e-15 |
6.637e-14 |
206 |
PROTEIN MATURATION |
35 |
265 |
3.258e-15 |
7.36e-14 |
207 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
47 |
472 |
3.861e-15 |
8.679e-14 |
208 |
PEPTIDYL AMINO ACID MODIFICATION |
65 |
841 |
4.633e-15 |
1.036e-13 |
209 |
GLAND MORPHOGENESIS |
22 |
97 |
5.74e-15 |
1.278e-13 |
210 |
CELLULAR HOMEOSTASIS |
57 |
676 |
6.442e-15 |
1.427e-13 |
211 |
POSITIVE REGULATION OF CHEMOTAXIS |
24 |
120 |
6.838e-15 |
1.508e-13 |
212 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
54 |
616 |
7.031e-15 |
1.543e-13 |
213 |
POSITIVE REGULATION OF LEUKOCYTE MIGRATION |
23 |
109 |
7.374e-15 |
1.611e-13 |
214 |
REGULATION OF CYTOPLASMIC TRANSPORT |
47 |
481 |
7.91e-15 |
1.72e-13 |
215 |
RESPONSE TO PURINE CONTAINING COMPOUND |
27 |
158 |
8.428e-15 |
1.824e-13 |
216 |
TUBE MORPHOGENESIS |
38 |
323 |
9.463e-15 |
2.039e-13 |
217 |
REGULATION OF INNATE IMMUNE RESPONSE |
40 |
357 |
9.585e-15 |
2.055e-13 |
218 |
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
30 |
200 |
1.027e-14 |
2.191e-13 |
219 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
27 |
162 |
1.598e-14 |
3.394e-13 |
220 |
RESPONSE TO CORTICOSTEROID |
28 |
176 |
1.756e-14 |
3.714e-13 |
221 |
REGULATION OF CELL MORPHOGENESIS |
50 |
552 |
2.109e-14 |
4.44e-13 |
222 |
EPITHELIAL CELL DIFFERENTIATION |
47 |
495 |
2.328e-14 |
4.879e-13 |
223 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
50 |
554 |
2.429e-14 |
5.068e-13 |
224 |
RESPONSE TO PEPTIDE |
42 |
404 |
2.749e-14 |
5.711e-13 |
225 |
REGULATION OF CHEMOTAXIS |
28 |
180 |
3.153e-14 |
6.496e-13 |
226 |
CONNECTIVE TISSUE DEVELOPMENT |
29 |
194 |
3.155e-14 |
6.496e-13 |
227 |
LEUKOCYTE CHEMOTAXIS |
23 |
117 |
3.718e-14 |
7.622e-13 |
228 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
49 |
541 |
3.916e-14 |
7.956e-13 |
229 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
49 |
541 |
3.916e-14 |
7.956e-13 |
230 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
56 |
684 |
3.947e-14 |
7.986e-13 |
231 |
RESPONSE TO KETONE |
28 |
182 |
4.198e-14 |
8.457e-13 |
232 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION |
30 |
211 |
4.44e-14 |
8.904e-13 |
233 |
CELL FATE COMMITMENT |
31 |
227 |
5.113e-14 |
1.021e-12 |
234 |
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
27 |
171 |
6.278e-14 |
1.248e-12 |
235 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
47 |
513 |
8.775e-14 |
1.737e-12 |
236 |
REGULATION OF ORGANELLE ORGANIZATION |
77 |
1178 |
8.902e-14 |
1.755e-12 |
237 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
34 |
279 |
8.983e-14 |
1.764e-12 |
238 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
39 |
365 |
9.852e-14 |
1.926e-12 |
239 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
33 |
264 |
1.013e-13 |
1.972e-12 |
240 |
CELLULAR RESPONSE TO ACID CHEMICAL |
27 |
175 |
1.121e-13 |
2.173e-12 |
241 |
RHYTHMIC PROCESS |
35 |
298 |
1.167e-13 |
2.253e-12 |
242 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
42 |
422 |
1.224e-13 |
2.353e-12 |
243 |
POSITIVE REGULATION OF RESPONSE TO WOUNDING |
26 |
162 |
1.24e-13 |
2.374e-12 |
244 |
MESENCHYME DEVELOPMENT |
28 |
190 |
1.27e-13 |
2.422e-12 |
245 |
EMBRYONIC MORPHOGENESIS |
48 |
539 |
1.363e-13 |
2.58e-12 |
246 |
REGULATION OF BINDING |
34 |
283 |
1.364e-13 |
2.58e-12 |
247 |
POSITIVE REGULATION OF HEMOPOIESIS |
26 |
163 |
1.44e-13 |
2.712e-12 |
248 |
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT |
39 |
370 |
1.528e-13 |
2.867e-12 |
249 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
24 |
138 |
1.779e-13 |
3.325e-12 |
250 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
25 |
153 |
2.425e-13 |
4.513e-12 |
251 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
23 |
129 |
3.301e-13 |
6.094e-12 |
252 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
48 |
552 |
3.297e-13 |
6.094e-12 |
253 |
MULTI MULTICELLULAR ORGANISM PROCESS |
29 |
213 |
3.67e-13 |
6.749e-12 |
254 |
NEGATIVE REGULATION OF NEURON DEATH |
26 |
171 |
4.57e-13 |
8.372e-12 |
255 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
24 |
144 |
4.691e-13 |
8.559e-12 |
256 |
REGULATION OF VASCULATURE DEVELOPMENT |
30 |
233 |
6.311e-13 |
1.147e-11 |
257 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
33 |
282 |
6.627e-13 |
1.2e-11 |
258 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
29 |
218 |
6.682e-13 |
1.205e-11 |
259 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
20 |
98 |
8.347e-13 |
1.5e-11 |
260 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
62 |
872 |
8.629e-13 |
1.544e-11 |
261 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
36 |
337 |
9.125e-13 |
1.627e-11 |
262 |
REGULATION OF SYSTEM PROCESS |
45 |
507 |
9.255e-13 |
1.644e-11 |
263 |
REGULATION OF LEUKOCYTE PROLIFERATION |
28 |
206 |
9.818e-13 |
1.737e-11 |
264 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
60 |
829 |
9.862e-13 |
1.738e-11 |
265 |
POSITIVE REGULATION OF GROWTH |
30 |
238 |
1.103e-12 |
1.929e-11 |
266 |
CELLULAR COMPONENT MORPHOGENESIS |
63 |
900 |
1.1e-12 |
1.929e-11 |
267 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
20 |
100 |
1.246e-12 |
2.166e-11 |
268 |
NEGATIVE REGULATION OF CELL CYCLE |
41 |
433 |
1.248e-12 |
2.166e-11 |
269 |
REGULATION OF DEVELOPMENTAL GROWTH |
33 |
289 |
1.319e-12 |
2.273e-11 |
270 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
33 |
289 |
1.319e-12 |
2.273e-11 |
271 |
SENSORY ORGAN DEVELOPMENT |
44 |
493 |
1.39e-12 |
2.387e-11 |
272 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
24 |
152 |
1.582e-12 |
2.707e-11 |
273 |
MUSCLE TISSUE DEVELOPMENT |
32 |
275 |
1.742e-12 |
2.968e-11 |
274 |
POSITIVE REGULATION OF PROTEIN SECRETION |
28 |
211 |
1.785e-12 |
3.031e-11 |
275 |
IN UTERO EMBRYONIC DEVELOPMENT |
34 |
311 |
2.073e-12 |
3.494e-11 |
276 |
HEMOSTASIS |
34 |
311 |
2.073e-12 |
3.494e-11 |
277 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
21 |
115 |
2.194e-12 |
3.685e-11 |
278 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
20 |
103 |
2.229e-12 |
3.731e-11 |
279 |
REGULATION OF PROTEIN IMPORT |
26 |
183 |
2.285e-12 |
3.811e-11 |
280 |
PROTEOLYSIS |
75 |
1208 |
2.522e-12 |
4.192e-11 |
281 |
POSITIVE REGULATION OF PROTEIN IMPORT |
20 |
104 |
2.693e-12 |
4.46e-11 |
282 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
31 |
263 |
2.776e-12 |
4.58e-11 |
283 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
29 |
232 |
3.268e-12 |
5.373e-11 |
284 |
REGULATION OF FAT CELL DIFFERENTIATION |
20 |
106 |
3.906e-12 |
6.4e-11 |
285 |
POSITIVE REGULATION OF OSSIFICATION |
18 |
84 |
4.866e-12 |
7.945e-11 |
286 |
RESPONSE TO RADIATION |
39 |
413 |
4.908e-12 |
7.985e-11 |
287 |
STEM CELL DIFFERENTIATION |
26 |
190 |
5.496e-12 |
8.911e-11 |
288 |
REGULATION OF DNA METABOLIC PROCESS |
35 |
340 |
5.546e-12 |
8.955e-11 |
289 |
POSITIVE REGULATION OF CYTOKINE SECRETION |
19 |
96 |
5.562e-12 |
8.955e-11 |
290 |
REGULATION OF PROTEIN KINASE B SIGNALING |
21 |
121 |
6.113e-12 |
9.809e-11 |
291 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
24 |
162 |
6.485e-12 |
1.037e-10 |
292 |
NEGATIVE REGULATION OF CELL ADHESION |
28 |
223 |
6.968e-12 |
1.11e-10 |
293 |
COLLAGEN FIBRIL ORGANIZATION |
13 |
38 |
7.038e-12 |
1.118e-10 |
294 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
22 |
135 |
7.084e-12 |
1.121e-10 |
295 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
18 |
86 |
7.439e-12 |
1.173e-10 |
296 |
GLIAL CELL DIFFERENTIATION |
22 |
136 |
8.248e-12 |
1.297e-10 |
297 |
NEURON DIFFERENTIATION |
60 |
874 |
8.995e-12 |
1.409e-10 |
298 |
RESPONSE TO EXTRACELLULAR STIMULUS |
40 |
441 |
9.184e-12 |
1.434e-10 |
299 |
REGULATION OF ORGAN MORPHOGENESIS |
29 |
242 |
9.425e-12 |
1.467e-10 |
300 |
PROTEIN COMPLEX SUBUNIT ORGANIZATION |
86 |
1527 |
9.511e-12 |
1.475e-10 |
301 |
PLACENTA DEVELOPMENT |
22 |
138 |
1.113e-11 |
1.721e-10 |
302 |
HEART MORPHOGENESIS |
27 |
212 |
1.189e-11 |
1.832e-10 |
303 |
RESPONSE TO ORGANOPHOSPHORUS |
22 |
139 |
1.291e-11 |
1.983e-10 |
304 |
IMMUNE EFFECTOR PROCESS |
42 |
486 |
1.304e-11 |
1.996e-10 |
305 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
55 |
767 |
1.354e-11 |
2.066e-10 |
306 |
CELLULAR CHEMICAL HOMEOSTASIS |
46 |
570 |
1.41e-11 |
2.138e-10 |
307 |
DEVELOPMENTAL GROWTH |
34 |
333 |
1.41e-11 |
2.138e-10 |
308 |
GROWTH |
38 |
410 |
1.629e-11 |
2.461e-10 |
309 |
UROGENITAL SYSTEM DEVELOPMENT |
32 |
299 |
1.653e-11 |
2.489e-10 |
310 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
19 |
103 |
2.053e-11 |
3.081e-10 |
311 |
RESPONSE TO INTERFERON GAMMA |
22 |
144 |
2.653e-11 |
3.969e-10 |
312 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
35 |
360 |
2.799e-11 |
4.174e-10 |
313 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
27 |
220 |
2.841e-11 |
4.223e-10 |
314 |
MYELOID CELL DIFFERENTIATION |
25 |
189 |
3.008e-11 |
4.458e-10 |
315 |
MUSCLE CELL DIFFERENTIATION |
28 |
237 |
3.04e-11 |
4.491e-10 |
316 |
REGULATION OF PROTEIN TARGETING |
32 |
307 |
3.318e-11 |
4.886e-10 |
317 |
REGULATION OF ERK1 AND ERK2 CASCADE |
28 |
238 |
3.363e-11 |
4.936e-10 |
318 |
FAT CELL DIFFERENTIATION |
19 |
106 |
3.474e-11 |
5.084e-10 |
319 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
26 |
207 |
3.934e-11 |
5.738e-10 |
320 |
MESENCHYMAL CELL DIFFERENTIATION |
21 |
134 |
4.591e-11 |
6.675e-10 |
321 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
20 |
121 |
4.926e-11 |
7.14e-10 |
322 |
EMBRYONIC ORGAN DEVELOPMENT |
37 |
406 |
4.956e-11 |
7.161e-10 |
323 |
MYELOID LEUKOCYTE DIFFERENTIATION |
18 |
96 |
5.233e-11 |
7.515e-10 |
324 |
REGULATION OF LEUKOCYTE CHEMOTAXIS |
18 |
96 |
5.233e-11 |
7.515e-10 |
325 |
INTERSPECIES INTERACTION BETWEEN ORGANISMS |
49 |
662 |
6.378e-11 |
9.104e-10 |
326 |
SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
49 |
662 |
6.378e-11 |
9.104e-10 |
327 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
27 |
228 |
6.518e-11 |
9.274e-10 |
328 |
HEAD DEVELOPMENT |
51 |
709 |
7.093e-11 |
1.006e-09 |
329 |
POSITIVE REGULATION OF INNATE IMMUNE RESPONSE |
28 |
246 |
7.386e-11 |
1.045e-09 |
330 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
24 |
183 |
8.995e-11 |
1.268e-09 |
331 |
TISSUE REMODELING |
17 |
87 |
9.079e-11 |
1.276e-09 |
332 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
19 |
112 |
9.427e-11 |
1.321e-09 |
333 |
REGULATION OF CHEMOKINE PRODUCTION |
15 |
65 |
9.586e-11 |
1.335e-09 |
334 |
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
15 |
65 |
9.586e-11 |
1.335e-09 |
335 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
24 |
184 |
1.01e-10 |
1.402e-09 |
336 |
AMEBOIDAL TYPE CELL MIGRATION |
22 |
154 |
1.023e-10 |
1.416e-09 |
337 |
REGULATION OF STEM CELL DIFFERENTIATION |
19 |
113 |
1.106e-10 |
1.527e-09 |
338 |
POSITIVE REGULATION OF BINDING |
20 |
127 |
1.218e-10 |
1.677e-09 |
339 |
PEPTIDYL TYROSINE MODIFICATION |
24 |
186 |
1.269e-10 |
1.741e-09 |
340 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
35 |
381 |
1.347e-10 |
1.843e-09 |
341 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
27 |
236 |
1.44e-10 |
1.965e-09 |
342 |
REGULATION OF METAL ION TRANSPORT |
32 |
325 |
1.46e-10 |
1.986e-09 |
343 |
RESPONSE TO INTERLEUKIN 1 |
19 |
115 |
1.515e-10 |
2.055e-09 |
344 |
APOPTOTIC SIGNALING PATHWAY |
30 |
289 |
1.531e-10 |
2.07e-09 |
345 |
EYE DEVELOPMENT |
32 |
326 |
1.58e-10 |
2.13e-09 |
346 |
ACTIVATION OF INNATE IMMUNE RESPONSE |
25 |
204 |
1.601e-10 |
2.153e-09 |
347 |
MULTI ORGANISM REPRODUCTIVE PROCESS |
58 |
891 |
1.656e-10 |
2.221e-09 |
348 |
REGULATION OF RESPONSE TO CYTOKINE STIMULUS |
21 |
144 |
1.842e-10 |
2.463e-09 |
349 |
REGULATION OF WNT SIGNALING PATHWAY |
31 |
310 |
1.932e-10 |
2.575e-09 |
350 |
NEGATIVE REGULATION OF PROTEOLYSIS |
32 |
329 |
1.998e-10 |
2.656e-09 |
351 |
ACTIVATION OF IMMUNE RESPONSE |
37 |
427 |
2.095e-10 |
2.777e-09 |
352 |
HOMEOSTASIS OF NUMBER OF CELLS |
23 |
175 |
2.13e-10 |
2.816e-09 |
353 |
POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
20 |
131 |
2.162e-10 |
2.85e-09 |
354 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
24 |
191 |
2.215e-10 |
2.912e-09 |
355 |
CELLULAR RESPONSE TO MECHANICAL STIMULUS |
16 |
80 |
2.257e-10 |
2.958e-09 |
356 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
19 |
118 |
2.397e-10 |
3.133e-09 |
357 |
POSITIVE REGULATION OF SECRETION |
34 |
370 |
2.47e-10 |
3.219e-09 |
358 |
MUSCLE ORGAN DEVELOPMENT |
29 |
277 |
2.541e-10 |
3.303e-09 |
359 |
CARTILAGE DEVELOPMENT |
21 |
147 |
2.729e-10 |
3.528e-09 |
360 |
REGULATION OF CELL GROWTH |
35 |
391 |
2.73e-10 |
3.528e-09 |
361 |
POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING |
16 |
81 |
2.745e-10 |
3.529e-09 |
362 |
POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS |
16 |
81 |
2.745e-10 |
3.529e-09 |
363 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
34 |
372 |
2.85e-10 |
3.654e-09 |
364 |
REGULATION OF CELL PROJECTION ORGANIZATION |
43 |
558 |
2.896e-10 |
3.702e-09 |
365 |
RESPONSE TO TRANSITION METAL NANOPARTICLE |
21 |
148 |
3.104e-10 |
3.956e-09 |
366 |
CYTOKINE PRODUCTION |
19 |
120 |
3.228e-10 |
4.104e-09 |
367 |
REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS |
17 |
94 |
3.262e-10 |
4.136e-09 |
368 |
CELL CYCLE PROCESS |
65 |
1081 |
3.305e-10 |
4.179e-09 |
369 |
RESPONSE TO PROGESTERONE |
13 |
50 |
3.459e-10 |
4.362e-09 |
370 |
LEUKOCYTE HOMEOSTASIS |
14 |
60 |
3.471e-10 |
4.365e-09 |
371 |
ORGAN REGENERATION |
16 |
83 |
4.026e-10 |
5.036e-09 |
372 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
37 |
437 |
4.019e-10 |
5.036e-09 |
373 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
24 |
197 |
4.219e-10 |
5.25e-09 |
374 |
POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY |
24 |
197 |
4.219e-10 |
5.25e-09 |
375 |
CELLULAR RESPONSE TO INTERFERON GAMMA |
19 |
122 |
4.322e-10 |
5.362e-09 |
376 |
CARDIOCYTE DIFFERENTIATION |
17 |
96 |
4.6e-10 |
5.693e-09 |
377 |
FORMATION OF PRIMARY GERM LAYER |
18 |
110 |
5.436e-10 |
6.709e-09 |
378 |
POSITIVE REGULATION OF HOMEOSTATIC PROCESS |
25 |
216 |
5.453e-10 |
6.712e-09 |
379 |
NEGATIVE REGULATION OF CELL CELL ADHESION |
20 |
138 |
5.606e-10 |
6.883e-09 |
380 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
30 |
306 |
6.149e-10 |
7.53e-09 |
381 |
POSITIVE REGULATION OF DNA METABOLIC PROCESS |
23 |
185 |
6.531e-10 |
7.976e-09 |
382 |
CELL CYCLE ARREST |
21 |
154 |
6.568e-10 |
8e-09 |
383 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
25 |
218 |
6.63e-10 |
8.055e-09 |
384 |
ENDOCYTOSIS |
40 |
509 |
7.025e-10 |
8.512e-09 |
385 |
BONE DEVELOPMENT |
21 |
156 |
8.363e-10 |
1.008e-08 |
386 |
CELLULAR RESPONSE TO INORGANIC SUBSTANCE |
21 |
156 |
8.363e-10 |
1.008e-08 |
387 |
POSITIVE REGULATION OF INFLAMMATORY RESPONSE |
18 |
113 |
8.551e-10 |
1.028e-08 |
388 |
CELL CYCLE |
73 |
1316 |
8.783e-10 |
1.053e-08 |
389 |
PLATELET ACTIVATION |
20 |
142 |
9.404e-10 |
1.125e-08 |
390 |
NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY |
16 |
88 |
9.992e-10 |
1.189e-08 |
391 |
POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
16 |
88 |
9.992e-10 |
1.189e-08 |
392 |
EXTRACELLULAR MATRIX DISASSEMBLY |
15 |
76 |
1.007e-09 |
1.196e-08 |
393 |
REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
17 |
101 |
1.046e-09 |
1.238e-08 |
394 |
POSITIVE REGULATION OF CELL CYCLE |
31 |
332 |
1.053e-09 |
1.244e-08 |
395 |
MULTICELLULAR ORGANISM REPRODUCTION |
51 |
768 |
1.164e-09 |
1.371e-08 |
396 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
24 |
207 |
1.168e-09 |
1.373e-08 |
397 |
RESPONSE TO IONIZING RADIATION |
20 |
145 |
1.369e-09 |
1.601e-08 |
398 |
NEGATIVE REGULATION OF MAPK CASCADE |
20 |
145 |
1.369e-09 |
1.601e-08 |
399 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
33 |
375 |
1.382e-09 |
1.611e-08 |
400 |
REGULATION OF CALCIUM ION TRANSPORT |
24 |
209 |
1.421e-09 |
1.653e-08 |
401 |
MAMMARY GLAND DEVELOPMENT |
18 |
117 |
1.529e-09 |
1.774e-08 |
402 |
REGULATION OF CYTOSKELETON ORGANIZATION |
39 |
502 |
1.603e-09 |
1.855e-08 |
403 |
CELL AGING |
14 |
67 |
1.655e-09 |
1.911e-08 |
404 |
RESPONSE TO CAMP |
17 |
104 |
1.671e-09 |
1.925e-08 |
405 |
SKIN DEVELOPMENT |
24 |
211 |
1.725e-09 |
1.982e-08 |
406 |
REGULATION OF LIPID METABOLIC PROCESS |
28 |
282 |
1.739e-09 |
1.993e-08 |
407 |
REGULATION OF T CELL PROLIFERATION |
20 |
147 |
1.75e-09 |
2e-08 |
408 |
BONE MORPHOGENESIS |
15 |
79 |
1.779e-09 |
2.029e-08 |
409 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
25 |
229 |
1.865e-09 |
2.122e-08 |
410 |
RESPONSE TO VIRUS |
26 |
247 |
1.934e-09 |
2.195e-08 |
411 |
POSITIVE REGULATION OF CELL GROWTH |
20 |
148 |
1.974e-09 |
2.235e-08 |
412 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN |
14 |
68 |
2.035e-09 |
2.298e-08 |
413 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
29 |
303 |
2.083e-09 |
2.346e-08 |
414 |
REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
11 |
38 |
2.282e-09 |
2.565e-08 |
415 |
REGULATION OF INTERLEUKIN 1 PRODUCTION |
13 |
58 |
2.54e-09 |
2.848e-08 |
416 |
REGULATION OF MITOTIC CELL CYCLE |
37 |
468 |
2.658e-09 |
2.973e-08 |
417 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
34 |
406 |
2.789e-09 |
3.108e-08 |
418 |
ADAPTIVE IMMUNE RESPONSE |
28 |
288 |
2.792e-09 |
3.108e-08 |
419 |
POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION |
19 |
136 |
2.845e-09 |
3.159e-08 |
420 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
18 |
122 |
3.053e-09 |
3.382e-08 |
421 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
34 |
408 |
3.162e-09 |
3.494e-08 |
422 |
REGULATION OF PROTEIN BINDING |
21 |
168 |
3.291e-09 |
3.62e-08 |
423 |
RESPONSE TO CARBOHYDRATE |
21 |
168 |
3.291e-09 |
3.62e-08 |
424 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
37 |
472 |
3.347e-09 |
3.673e-08 |
425 |
ENDOCRINE SYSTEM DEVELOPMENT |
18 |
123 |
3.491e-09 |
3.822e-08 |
426 |
PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY |
17 |
109 |
3.518e-09 |
3.841e-08 |
427 |
POSITIVE REGULATION OF CHEMOKINE PRODUCTION |
12 |
49 |
3.525e-09 |
3.841e-08 |
428 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
13 |
60 |
3.965e-09 |
4.3e-08 |
429 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
13 |
60 |
3.965e-09 |
4.3e-08 |
430 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
12 |
50 |
4.529e-09 |
4.901e-08 |
431 |
NEGATIVE REGULATION OF TRANSPORT |
36 |
458 |
5.111e-09 |
5.518e-08 |
432 |
RESPONSE TO VITAMIN |
16 |
98 |
5.139e-09 |
5.535e-08 |
433 |
REGULATION OF WOUND HEALING |
18 |
126 |
5.175e-09 |
5.561e-08 |
434 |
RESPONSE TO AMINO ACID |
17 |
112 |
5.388e-09 |
5.777e-08 |
435 |
POSITIVE REGULATION OF STAT CASCADE |
14 |
73 |
5.415e-09 |
5.779e-08 |
436 |
POSITIVE REGULATION OF JAK STAT CASCADE |
14 |
73 |
5.415e-09 |
5.779e-08 |
437 |
REGULATION OF ION TRANSPORT |
42 |
592 |
5.538e-09 |
5.896e-08 |
438 |
REGULATION OF VITAMIN METABOLIC PROCESS |
7 |
12 |
5.756e-09 |
6.115e-08 |
439 |
EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
16 |
99 |
5.984e-09 |
6.342e-08 |
440 |
RESPONSE TO NUTRIENT |
22 |
191 |
6.523e-09 |
6.898e-08 |
441 |
MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
15 |
87 |
7.163e-09 |
7.457e-08 |
442 |
ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
15 |
87 |
7.163e-09 |
7.457e-08 |
443 |
VIRAL ENTRY INTO HOST CELL |
15 |
87 |
7.163e-09 |
7.457e-08 |
444 |
ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
15 |
87 |
7.163e-09 |
7.457e-08 |
445 |
MOVEMENT IN HOST ENVIRONMENT |
15 |
87 |
7.163e-09 |
7.457e-08 |
446 |
ENTRY INTO HOST |
15 |
87 |
7.163e-09 |
7.457e-08 |
447 |
ENTRY INTO HOST CELL |
15 |
87 |
7.163e-09 |
7.457e-08 |
448 |
POSITIVE REGULATION OF DNA BINDING |
11 |
42 |
7.383e-09 |
7.668e-08 |
449 |
REGULATION OF CARTILAGE DEVELOPMENT |
13 |
63 |
7.476e-09 |
7.748e-08 |
450 |
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
14 |
75 |
7.826e-09 |
8.092e-08 |
451 |
CELLULAR RESPONSE TO ALCOHOL |
17 |
115 |
8.136e-09 |
8.393e-08 |
452 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
28 |
303 |
8.606e-09 |
8.859e-08 |
453 |
CELL CELL SIGNALING |
49 |
767 |
8.829e-09 |
9.069e-08 |
454 |
REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS |
12 |
53 |
9.267e-09 |
9.497e-08 |
455 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
16 |
102 |
9.338e-09 |
9.55e-08 |
456 |
RESPONSE TO ESTRADIOL |
19 |
146 |
9.447e-09 |
9.64e-08 |
457 |
REGULATION OF MUSCLE SYSTEM PROCESS |
22 |
195 |
9.592e-09 |
9.766e-08 |
458 |
CELLULAR COMPONENT DISASSEMBLY |
38 |
515 |
1.066e-08 |
1.083e-07 |
459 |
CIRCULATORY SYSTEM PROCESS |
31 |
366 |
1.086e-08 |
1.101e-07 |
460 |
REGULATION OF LYMPHOCYTE DIFFERENTIATION |
18 |
132 |
1.099e-08 |
1.112e-07 |
461 |
RESPONSE TO TUMOR NECROSIS FACTOR |
24 |
233 |
1.247e-08 |
1.259e-07 |
462 |
NEGATIVE REGULATION OF MITOTIC CELL CYCLE |
22 |
199 |
1.396e-08 |
1.406e-07 |
463 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
14 |
79 |
1.578e-08 |
1.585e-07 |
464 |
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
15 |
92 |
1.581e-08 |
1.585e-07 |
465 |
REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS |
11 |
45 |
1.631e-08 |
1.632e-07 |
466 |
POSITIVE REGULATION OF NEURON DEATH |
13 |
67 |
1.647e-08 |
1.641e-07 |
467 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
13 |
67 |
1.647e-08 |
1.641e-07 |
468 |
REGULATION OF ION HOMEOSTASIS |
22 |
201 |
1.678e-08 |
1.668e-07 |
469 |
CELLULAR RESPONSE TO PEPTIDE |
26 |
274 |
1.709e-08 |
1.692e-07 |
470 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
26 |
274 |
1.709e-08 |
1.692e-07 |
471 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
17 |
121 |
1.783e-08 |
1.761e-07 |
472 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
15 |
93 |
1.84e-08 |
1.814e-07 |
473 |
NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT |
14 |
80 |
1.867e-08 |
1.837e-07 |
474 |
DEFENSE RESPONSE TO OTHER ORGANISM |
37 |
505 |
2.015e-08 |
1.978e-07 |
475 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
40 |
573 |
2.029e-08 |
1.987e-07 |
476 |
NEGATIVE REGULATION OF HYDROLASE ACTIVITY |
32 |
397 |
2.052e-08 |
2.005e-07 |
477 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
19 |
154 |
2.292e-08 |
2.236e-07 |
478 |
ION HOMEOSTASIS |
40 |
576 |
2.341e-08 |
2.279e-07 |
479 |
RESPONSE TO HYDROGEN PEROXIDE |
16 |
109 |
2.481e-08 |
2.41e-07 |
480 |
CELLULAR RESPONSE TO DNA DAMAGE STIMULUS |
46 |
720 |
2.581e-08 |
2.502e-07 |
481 |
INOSITOL LIPID MEDIATED SIGNALING |
17 |
124 |
2.591e-08 |
2.506e-07 |
482 |
THYMUS DEVELOPMENT |
11 |
47 |
2.668e-08 |
2.576e-07 |
483 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
20 |
172 |
2.709e-08 |
2.61e-07 |
484 |
INTERFERON GAMMA MEDIATED SIGNALING PATHWAY |
13 |
70 |
2.867e-08 |
2.757e-07 |
485 |
STRIATED MUSCLE CELL DIFFERENTIATION |
20 |
173 |
2.99e-08 |
2.868e-07 |
486 |
NEGATIVE REGULATION OF PEPTIDASE ACTIVITY |
24 |
245 |
3.308e-08 |
3.167e-07 |
487 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
11 |
48 |
3.381e-08 |
3.23e-07 |
488 |
NEGATIVE REGULATION OF CELL ACTIVATION |
19 |
158 |
3.491e-08 |
3.329e-07 |
489 |
REGULATION OF CATABOLIC PROCESS |
46 |
731 |
4.06e-08 |
3.863e-07 |
490 |
CHONDROCYTE DIFFERENTIATION |
12 |
60 |
4.114e-08 |
3.907e-07 |
491 |
SYSTEM PROCESS |
85 |
1785 |
4.296e-08 |
4.071e-07 |
492 |
REGULATION OF JAK STAT CASCADE |
18 |
144 |
4.375e-08 |
4.129e-07 |
493 |
REGULATION OF STAT CASCADE |
18 |
144 |
4.375e-08 |
4.129e-07 |
494 |
ACUTE INFLAMMATORY RESPONSE |
13 |
73 |
4.851e-08 |
4.56e-07 |
495 |
REGULATION OF ORGAN GROWTH |
13 |
73 |
4.851e-08 |
4.56e-07 |
496 |
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
18 |
145 |
4.875e-08 |
4.564e-07 |
497 |
REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS |
18 |
145 |
4.875e-08 |
4.564e-07 |
498 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
23 |
232 |
5.128e-08 |
4.791e-07 |
499 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
19 |
162 |
5.245e-08 |
4.891e-07 |
500 |
LYMPHOCYTE HOMEOSTASIS |
11 |
50 |
5.33e-08 |
4.96e-07 |
501 |
CYTOSKELETON ORGANIZATION |
50 |
838 |
5.476e-08 |
5.085e-07 |
502 |
REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
23 |
233 |
5.553e-08 |
5.147e-07 |
503 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
21 |
197 |
5.629e-08 |
5.207e-07 |
504 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
13 |
74 |
5.746e-08 |
5.305e-07 |
505 |
REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
15 |
101 |
5.782e-08 |
5.327e-07 |
506 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
12 |
62 |
6.056e-08 |
5.569e-07 |
507 |
LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY |
9 |
31 |
6.551e-08 |
6.013e-07 |
508 |
CELLULAR RESPONSE TO INTERLEUKIN 1 |
14 |
88 |
6.573e-08 |
6.021e-07 |
509 |
NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION |
15 |
102 |
6.618e-08 |
6.05e-07 |
510 |
POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY |
17 |
132 |
6.648e-08 |
6.054e-07 |
511 |
REGULATION OF INTERLEUKIN 12 PRODUCTION |
11 |
51 |
6.637e-08 |
6.054e-07 |
512 |
NEGATIVE REGULATION OF GROWTH |
23 |
236 |
7.032e-08 |
6.39e-07 |
513 |
REGULATION OF EPIDERMIS DEVELOPMENT |
12 |
63 |
7.305e-08 |
6.626e-07 |
514 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
10 |
41 |
7.559e-08 |
6.843e-07 |
515 |
DEFENSE RESPONSE TO BACTERIUM |
23 |
237 |
7.601e-08 |
6.867e-07 |
516 |
SKELETAL SYSTEM MORPHOGENESIS |
21 |
201 |
7.971e-08 |
7.188e-07 |
517 |
TISSUE REGENERATION |
11 |
52 |
8.22e-08 |
7.384e-07 |
518 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
11 |
52 |
8.22e-08 |
7.384e-07 |
519 |
INTERACTION WITH HOST |
17 |
134 |
8.319e-08 |
7.458e-07 |
520 |
REGULATION OF INTERLEUKIN 6 PRODUCTION |
15 |
104 |
8.627e-08 |
7.719e-07 |
521 |
CELL PROJECTION ORGANIZATION |
52 |
902 |
8.779e-08 |
7.84e-07 |
522 |
REGULATION OF OXIDOREDUCTASE ACTIVITY |
14 |
90 |
8.805e-08 |
7.849e-07 |
523 |
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
24 |
258 |
8.862e-08 |
7.884e-07 |
524 |
NEGATIVE REGULATION OF CATABOLIC PROCESS |
21 |
203 |
9.452e-08 |
8.394e-07 |
525 |
REGULATION OF IMMUNE EFFECTOR PROCESS |
32 |
424 |
9.494e-08 |
8.414e-07 |
526 |
EPITHELIAL CELL DEVELOPMENT |
20 |
186 |
1.009e-07 |
8.928e-07 |
527 |
POSITIVE REGULATION OF FIBROBLAST PROLIFERATION |
11 |
53 |
1.013e-07 |
8.928e-07 |
528 |
CELLULAR RESPONSE TO AMINO ACID STIMULUS |
11 |
53 |
1.013e-07 |
8.928e-07 |
529 |
RESPONSE TO ETHANOL |
17 |
136 |
1.036e-07 |
9.116e-07 |
530 |
RENAL TUBULE DEVELOPMENT |
13 |
78 |
1.1e-07 |
9.659e-07 |
531 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT |
15 |
106 |
1.117e-07 |
9.791e-07 |
532 |
GLUCOSE HOMEOSTASIS |
19 |
170 |
1.14e-07 |
9.948e-07 |
533 |
CARBOHYDRATE HOMEOSTASIS |
19 |
170 |
1.14e-07 |
9.948e-07 |
534 |
CIRCADIAN RHYTHM |
17 |
137 |
1.155e-07 |
1.006e-06 |
535 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
28 |
343 |
1.221e-07 |
1.062e-06 |
536 |
ALPHA BETA T CELL ACTIVATION |
11 |
54 |
1.242e-07 |
1.079e-06 |
537 |
REGULATION OF DNA BINDING |
14 |
93 |
1.345e-07 |
1.165e-06 |
538 |
GASTRULATION |
18 |
155 |
1.369e-07 |
1.184e-06 |
539 |
NEURON PROJECTION DEVELOPMENT |
37 |
545 |
1.414e-07 |
1.221e-06 |
540 |
CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE |
17 |
139 |
1.43e-07 |
1.232e-06 |
541 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
20 |
190 |
1.435e-07 |
1.234e-06 |
542 |
POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION |
13 |
80 |
1.499e-07 |
1.287e-06 |
543 |
NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
11 |
55 |
1.517e-07 |
1.297e-06 |
544 |
REGULATION OF KIDNEY DEVELOPMENT |
11 |
55 |
1.517e-07 |
1.297e-06 |
545 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
9 |
34 |
1.589e-07 |
1.357e-06 |
546 |
TELENCEPHALON DEVELOPMENT |
22 |
228 |
1.613e-07 |
1.375e-06 |
547 |
POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION |
13 |
81 |
1.744e-07 |
1.483e-06 |
548 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
14 |
95 |
1.766e-07 |
1.5e-06 |
549 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
11 |
56 |
1.843e-07 |
1.56e-06 |
550 |
OUTFLOW TRACT MORPHOGENESIS |
11 |
56 |
1.843e-07 |
1.56e-06 |
551 |
ALPHA BETA T CELL DIFFERENTIATION |
10 |
45 |
1.958e-07 |
1.653e-06 |
552 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
28 |
351 |
1.968e-07 |
1.659e-06 |
553 |
NEGATIVE REGULATION OF OSSIFICATION |
12 |
69 |
2.092e-07 |
1.76e-06 |
554 |
EAR DEVELOPMENT |
20 |
195 |
2.197e-07 |
1.845e-06 |
555 |
REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
11 |
57 |
2.231e-07 |
1.867e-06 |
556 |
ENDOTHELIAL CELL MIGRATION |
11 |
57 |
2.231e-07 |
1.867e-06 |
557 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND |
10 |
46 |
2.443e-07 |
2.037e-06 |
558 |
REGULATION OF CHONDROCYTE DIFFERENTIATION |
10 |
46 |
2.443e-07 |
2.037e-06 |
559 |
HEPATICOBILIARY SYSTEM DEVELOPMENT |
16 |
128 |
2.456e-07 |
2.041e-06 |
560 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
16 |
128 |
2.456e-07 |
2.041e-06 |
561 |
EPIDERMIS DEVELOPMENT |
23 |
253 |
2.488e-07 |
2.064e-06 |
562 |
POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
19 |
179 |
2.579e-07 |
2.135e-06 |
563 |
RESPIRATORY SYSTEM DEVELOPMENT |
20 |
197 |
2.594e-07 |
2.144e-06 |
564 |
LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE |
14 |
98 |
2.624e-07 |
2.165e-06 |
565 |
CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS |
11 |
58 |
2.689e-07 |
2.21e-06 |
566 |
UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS |
11 |
58 |
2.689e-07 |
2.21e-06 |
567 |
TISSUE MIGRATION |
13 |
84 |
2.706e-07 |
2.221e-06 |
568 |
REGULATION OF ERYTHROCYTE DIFFERENTIATION |
9 |
36 |
2.722e-07 |
2.226e-06 |
569 |
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
9 |
36 |
2.722e-07 |
2.226e-06 |
570 |
REGULATION OF ENDOCYTOSIS |
20 |
199 |
3.056e-07 |
2.495e-06 |
571 |
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
13 |
85 |
3.119e-07 |
2.537e-06 |
572 |
TOLL LIKE RECEPTOR SIGNALING PATHWAY |
13 |
85 |
3.119e-07 |
2.537e-06 |
573 |
NEPHRON DEVELOPMENT |
15 |
115 |
3.327e-07 |
2.702e-06 |
574 |
GLIAL CELL MIGRATION |
9 |
37 |
3.514e-07 |
2.849e-06 |
575 |
POSITIVE REGULATION OF DNA REPLICATION |
13 |
86 |
3.588e-07 |
2.903e-06 |
576 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
10 |
48 |
3.741e-07 |
3.022e-06 |
577 |
MAINTENANCE OF CELL NUMBER |
16 |
132 |
3.764e-07 |
3.036e-06 |
578 |
POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE |
12 |
73 |
3.968e-07 |
3.194e-06 |
579 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
16 |
133 |
4.178e-07 |
3.357e-06 |
580 |
RESPONSE TO TOXIC SUBSTANCE |
22 |
241 |
4.224e-07 |
3.389e-06 |
581 |
NEGATIVE REGULATION OF ORGANELLE ORGANIZATION |
29 |
387 |
4.428e-07 |
3.546e-06 |
582 |
CELLULAR RESPONSE TO HYDROGEN PEROXIDE |
11 |
61 |
4.599e-07 |
3.658e-06 |
583 |
REGULATION OF INTERLEUKIN 8 PRODUCTION |
11 |
61 |
4.599e-07 |
3.658e-06 |
584 |
REGULATION OF STEROID BIOSYNTHETIC PROCESS |
10 |
49 |
4.59e-07 |
3.658e-06 |
585 |
LYMPHOCYTE MIGRATION |
10 |
49 |
4.59e-07 |
3.658e-06 |
586 |
CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS |
12 |
74 |
4.625e-07 |
3.66e-06 |
587 |
CARDIAC MUSCLE CELL DIFFERENTIATION |
12 |
74 |
4.625e-07 |
3.66e-06 |
588 |
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS |
6 |
13 |
4.613e-07 |
3.66e-06 |
589 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
23 |
262 |
4.634e-07 |
3.661e-06 |
590 |
PARTURITION |
7 |
20 |
4.694e-07 |
3.696e-06 |
591 |
REGULATION OF MONOCYTE CHEMOTAXIS |
7 |
20 |
4.694e-07 |
3.696e-06 |
592 |
REGULATION OF COAGULATION |
13 |
88 |
4.719e-07 |
3.703e-06 |
593 |
REGULATION OF STEM CELL PROLIFERATION |
13 |
88 |
4.719e-07 |
3.703e-06 |
594 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
14 |
103 |
4.91e-07 |
3.846e-06 |
595 |
RESPONSE TO INSULIN |
20 |
205 |
4.932e-07 |
3.851e-06 |
596 |
NEURON PROJECTION GUIDANCE |
20 |
205 |
4.932e-07 |
3.851e-06 |
597 |
ARTERY DEVELOPMENT |
12 |
75 |
5.376e-07 |
4.183e-06 |
598 |
NEURAL CREST CELL DIFFERENTIATION |
12 |
75 |
5.376e-07 |
4.183e-06 |
599 |
EPITHELIAL CELL PROLIFERATION |
13 |
89 |
5.396e-07 |
4.191e-06 |
600 |
CARDIAC CHAMBER MORPHOGENESIS |
14 |
104 |
5.539e-07 |
4.278e-06 |
601 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
19 |
188 |
5.534e-07 |
4.278e-06 |
602 |
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
8 |
29 |
5.562e-07 |
4.278e-06 |
603 |
REGULATION OF HEART MORPHOGENESIS |
8 |
29 |
5.562e-07 |
4.278e-06 |
604 |
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
8 |
29 |
5.562e-07 |
4.278e-06 |
605 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
14 |
104 |
5.539e-07 |
4.278e-06 |
606 |
REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT |
10 |
50 |
5.605e-07 |
4.282e-06 |
607 |
STAT CASCADE |
10 |
50 |
5.605e-07 |
4.282e-06 |
608 |
JAK STAT CASCADE |
10 |
50 |
5.605e-07 |
4.282e-06 |
609 |
RESPONSE TO GAMMA RADIATION |
10 |
50 |
5.605e-07 |
4.282e-06 |
610 |
EYE MORPHOGENESIS |
16 |
136 |
5.675e-07 |
4.329e-06 |
611 |
REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN |
9 |
39 |
5.714e-07 |
4.344e-06 |
612 |
ASTROCYTE DIFFERENTIATION |
9 |
39 |
5.714e-07 |
4.344e-06 |
613 |
PALLIUM DEVELOPMENT |
17 |
153 |
5.746e-07 |
4.361e-06 |
614 |
ODONTOGENESIS |
14 |
105 |
6.24e-07 |
4.729e-06 |
615 |
ENDOCRINE PANCREAS DEVELOPMENT |
9 |
40 |
7.203e-07 |
5.441e-06 |
616 |
ENDODERMAL CELL DIFFERENTIATION |
9 |
40 |
7.203e-07 |
5.441e-06 |
617 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
17 |
156 |
7.574e-07 |
5.702e-06 |
618 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
17 |
156 |
7.574e-07 |
5.702e-06 |
619 |
REGULATION OF PHOSPHOLIPASE ACTIVITY |
11 |
64 |
7.619e-07 |
5.727e-06 |
620 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
14 |
107 |
7.886e-07 |
5.887e-06 |
621 |
POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS |
6 |
14 |
7.894e-07 |
5.887e-06 |
622 |
REGULATION OF T CELL DIFFERENTIATION |
14 |
107 |
7.886e-07 |
5.887e-06 |
623 |
T CELL MIGRATION |
6 |
14 |
7.894e-07 |
5.887e-06 |
624 |
POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
6 |
14 |
7.894e-07 |
5.887e-06 |
625 |
PROTEIN COMPLEX BIOGENESIS |
58 |
1132 |
8.002e-07 |
5.948e-06 |
626 |
PROTEIN COMPLEX ASSEMBLY |
58 |
1132 |
8.002e-07 |
5.948e-06 |
627 |
POSITIVE REGULATION OF MITOTIC CELL CYCLE |
15 |
123 |
8.034e-07 |
5.962e-06 |
628 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
16 |
140 |
8.422e-07 |
6.24e-06 |
629 |
CELLULAR RESPONSE TO RETINOIC ACID |
11 |
65 |
8.957e-07 |
6.626e-06 |
630 |
POSITIVE REGULATION OF KIDNEY DEVELOPMENT |
9 |
41 |
9.016e-07 |
6.627e-06 |
631 |
AORTA DEVELOPMENT |
9 |
41 |
9.016e-07 |
6.627e-06 |
632 |
NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE |
9 |
41 |
9.016e-07 |
6.627e-06 |
633 |
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
9 |
41 |
9.016e-07 |
6.627e-06 |
634 |
NEURON DEVELOPMENT |
41 |
687 |
9.075e-07 |
6.629e-06 |
635 |
NEPHRON EPITHELIUM DEVELOPMENT |
13 |
93 |
9.055e-07 |
6.629e-06 |
636 |
POSITIVE REGULATION OF BLOOD CIRCULATION |
13 |
93 |
9.055e-07 |
6.629e-06 |
637 |
BEHAVIOR |
34 |
516 |
9.063e-07 |
6.629e-06 |
638 |
FOREBRAIN DEVELOPMENT |
27 |
357 |
9.259e-07 |
6.753e-06 |
639 |
REGULATION OF LEUKOCYTE APOPTOTIC PROCESS |
12 |
79 |
9.584e-07 |
6.979e-06 |
640 |
NEURON PROJECTION MORPHOGENESIS |
29 |
402 |
9.647e-07 |
7.014e-06 |
641 |
REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
7 |
22 |
9.867e-07 |
7.129e-06 |
642 |
REGULATION OF RESPONSE TO INTERFERON GAMMA |
7 |
22 |
9.867e-07 |
7.129e-06 |
643 |
REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS |
7 |
22 |
9.867e-07 |
7.129e-06 |
644 |
AORTA MORPHOGENESIS |
7 |
22 |
9.867e-07 |
7.129e-06 |
645 |
KIDNEY EPITHELIUM DEVELOPMENT |
15 |
125 |
9.899e-07 |
7.14e-06 |
646 |
REGULATION OF JNK CASCADE |
17 |
159 |
9.913e-07 |
7.14e-06 |
647 |
MESODERM MORPHOGENESIS |
11 |
66 |
1.05e-06 |
7.549e-06 |
648 |
MEMBRANE ORGANIZATION |
49 |
899 |
1.088e-06 |
7.813e-06 |
649 |
OSTEOBLAST DIFFERENTIATION |
15 |
126 |
1.097e-06 |
7.865e-06 |
650 |
REGULATION OF HEART GROWTH |
9 |
42 |
1.121e-06 |
8.025e-06 |
651 |
POSITIVE REGULATION OF T CELL PROLIFERATION |
13 |
95 |
1.161e-06 |
8.296e-06 |
652 |
POSITIVE REGULATION OF ION TRANSPORT |
21 |
236 |
1.172e-06 |
8.363e-06 |
653 |
REGULATION OF DNA REPLICATION |
17 |
161 |
1.182e-06 |
8.421e-06 |
654 |
POSITIVE REGULATION OF CALCIUM ION IMPORT |
10 |
54 |
1.189e-06 |
8.457e-06 |
655 |
SINGLE ORGANISM BEHAVIOR |
28 |
384 |
1.203e-06 |
8.547e-06 |
656 |
METANEPHROS DEVELOPMENT |
12 |
81 |
1.262e-06 |
8.939e-06 |
657 |
REGULATION OF FIBROBLAST PROLIFERATION |
12 |
81 |
1.262e-06 |
8.939e-06 |
658 |
SALIVARY GLAND DEVELOPMENT |
8 |
32 |
1.272e-06 |
8.967e-06 |
659 |
POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT |
8 |
32 |
1.272e-06 |
8.967e-06 |
660 |
NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
8 |
32 |
1.272e-06 |
8.967e-06 |
661 |
REGULATION OF LIPID BIOSYNTHETIC PROCESS |
15 |
128 |
1.343e-06 |
9.454e-06 |
662 |
RESPONSE TO INCREASED OXYGEN LEVELS |
7 |
23 |
1.386e-06 |
9.672e-06 |
663 |
REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
9 |
43 |
1.385e-06 |
9.672e-06 |
664 |
EMBRYONIC ORGAN MORPHOGENESIS |
23 |
279 |
1.386e-06 |
9.672e-06 |
665 |
LEUKOCYTE APOPTOTIC PROCESS |
7 |
23 |
1.386e-06 |
9.672e-06 |
666 |
RESPONSE TO HYPEROXIA |
7 |
23 |
1.386e-06 |
9.672e-06 |
667 |
ACUTE PHASE RESPONSE |
9 |
43 |
1.385e-06 |
9.672e-06 |
668 |
VASCULAR PROCESS IN CIRCULATORY SYSTEM |
17 |
163 |
1.405e-06 |
9.785e-06 |
669 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS |
10 |
55 |
1.419e-06 |
9.855e-06 |
670 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
10 |
55 |
1.419e-06 |
9.855e-06 |
671 |
NEGATIVE REGULATION OF SECRETION |
19 |
200 |
1.422e-06 |
9.861e-06 |
672 |
POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION |
11 |
68 |
1.429e-06 |
9.896e-06 |
673 |
SENSORY ORGAN MORPHOGENESIS |
21 |
239 |
1.438e-06 |
9.939e-06 |
674 |
KIDNEY MORPHOGENESIS |
12 |
82 |
1.444e-06 |
9.968e-06 |
675 |
REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
23 |
280 |
1.474e-06 |
1.016e-05 |
676 |
REGULATION OF MUSCLE CONTRACTION |
16 |
147 |
1.624e-06 |
1.117e-05 |
677 |
CELLULAR SENESCENCE |
8 |
33 |
1.641e-06 |
1.128e-05 |
678 |
EMBRYONIC PLACENTA DEVELOPMENT |
12 |
83 |
1.648e-06 |
1.131e-05 |
679 |
POSITIVE REGULATION OF AXONOGENESIS |
11 |
69 |
1.661e-06 |
1.138e-05 |
680 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
13 |
98 |
1.664e-06 |
1.139e-05 |
681 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
10 |
56 |
1.688e-06 |
1.153e-05 |
682 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
9 |
44 |
1.701e-06 |
1.159e-05 |
683 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
9 |
44 |
1.701e-06 |
1.159e-05 |
684 |
POSITIVE REGULATION OF ENDOCYTOSIS |
14 |
114 |
1.714e-06 |
1.166e-05 |
685 |
PEPTIDYL SERINE MODIFICATION |
16 |
148 |
1.777e-06 |
1.205e-05 |
686 |
DIGESTIVE SYSTEM DEVELOPMENT |
16 |
148 |
1.777e-06 |
1.205e-05 |
687 |
MYELOID LEUKOCYTE MIGRATION |
13 |
99 |
1.87e-06 |
1.265e-05 |
688 |
LIPID PHOSPHORYLATION |
13 |
99 |
1.87e-06 |
1.265e-05 |
689 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
12 |
84 |
1.878e-06 |
1.268e-05 |
690 |
REGULATION OF CELL CYCLE PROCESS |
35 |
558 |
1.929e-06 |
1.301e-05 |
691 |
CIRCADIAN REGULATION OF GENE EXPRESSION |
10 |
57 |
1.999e-06 |
1.344e-05 |
692 |
POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
10 |
57 |
1.999e-06 |
1.344e-05 |
693 |
EXOCRINE SYSTEM DEVELOPMENT |
9 |
45 |
2.078e-06 |
1.395e-05 |
694 |
PROTEIN KINASE B SIGNALING |
8 |
34 |
2.097e-06 |
1.404e-05 |
695 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS |
8 |
34 |
2.097e-06 |
1.404e-05 |
696 |
INTRACELLULAR RECEPTOR SIGNALING PATHWAY |
17 |
168 |
2.137e-06 |
1.427e-05 |
697 |
POSITIVE REGULATION OF CELL CYCLE ARREST |
12 |
85 |
2.135e-06 |
1.427e-05 |
698 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE |
11 |
71 |
2.224e-06 |
1.482e-05 |
699 |
NEGATIVE REGULATION OF CYTOKINE SECRETION |
9 |
46 |
2.524e-06 |
1.68e-05 |
700 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
19 |
208 |
2.557e-06 |
1.7e-05 |
701 |
CHEMOKINE MEDIATED SIGNALING PATHWAY |
11 |
72 |
2.564e-06 |
1.702e-05 |
702 |
NEGATIVE REGULATION OF PROTEIN PROCESSING |
8 |
35 |
2.656e-06 |
1.758e-05 |
703 |
NEGATIVE REGULATION OF PROTEIN MATURATION |
8 |
35 |
2.656e-06 |
1.758e-05 |
704 |
REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS |
10 |
59 |
2.775e-06 |
1.834e-05 |
705 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
21 |
250 |
2.952e-06 |
1.94e-05 |
706 |
REGULATION OF CALCIUM ION IMPORT |
13 |
103 |
2.942e-06 |
1.94e-05 |
707 |
CELLULAR RESPONSE TO KETONE |
11 |
73 |
2.948e-06 |
1.94e-05 |
708 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
11 |
73 |
2.948e-06 |
1.94e-05 |
709 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
18 |
191 |
3.008e-06 |
1.972e-05 |
710 |
ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS |
16 |
154 |
3.006e-06 |
1.972e-05 |
711 |
NEGATIVE REGULATION OF ANOIKIS |
6 |
17 |
3.042e-06 |
1.985e-05 |
712 |
POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY |
9 |
47 |
3.049e-06 |
1.985e-05 |
713 |
POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
6 |
17 |
3.042e-06 |
1.985e-05 |
714 |
POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS |
9 |
47 |
3.049e-06 |
1.985e-05 |
715 |
NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS |
6 |
17 |
3.042e-06 |
1.985e-05 |
716 |
MYELOID CELL HOMEOSTASIS |
12 |
88 |
3.104e-06 |
2.017e-05 |
717 |
VESICLE MEDIATED TRANSPORT |
60 |
1239 |
3.152e-06 |
2.046e-05 |
718 |
RESPONSE TO ALKALOID |
15 |
137 |
3.179e-06 |
2.055e-05 |
719 |
SKELETAL MUSCLE ORGAN DEVELOPMENT |
15 |
137 |
3.179e-06 |
2.055e-05 |
720 |
ACTIVATION OF MAPK ACTIVITY |
15 |
137 |
3.179e-06 |
2.055e-05 |
721 |
REGULATION OF SMOOTH MUSCLE CONTRACTION |
10 |
60 |
3.253e-06 |
2.099e-05 |
722 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
8 |
36 |
3.337e-06 |
2.147e-05 |
723 |
T CELL SELECTION |
8 |
36 |
3.337e-06 |
2.147e-05 |
724 |
DEVELOPMENTAL PROGRAMMED CELL DEATH |
7 |
26 |
3.475e-06 |
2.233e-05 |
725 |
RESPONSE TO HEAT |
12 |
89 |
3.504e-06 |
2.246e-05 |
726 |
B CELL DIFFERENTIATION |
12 |
89 |
3.504e-06 |
2.246e-05 |
727 |
REGULATION OF B CELL ACTIVATION |
14 |
121 |
3.512e-06 |
2.248e-05 |
728 |
NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS |
16 |
156 |
3.56e-06 |
2.272e-05 |
729 |
POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS |
16 |
156 |
3.56e-06 |
2.272e-05 |
730 |
CEREBRAL CORTEX DEVELOPMENT |
13 |
105 |
3.659e-06 |
2.332e-05 |
731 |
REGULATION OF INTERLEUKIN 1 BETA PRODUCTION |
9 |
48 |
3.667e-06 |
2.334e-05 |
732 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
11 |
75 |
3.871e-06 |
2.46e-05 |
733 |
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
12 |
90 |
3.948e-06 |
2.503e-05 |
734 |
MESONEPHROS DEVELOPMENT |
12 |
90 |
3.948e-06 |
2.503e-05 |
735 |
MYOBLAST DIFFERENTIATION |
8 |
37 |
4.16e-06 |
2.63e-05 |
736 |
POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN |
8 |
37 |
4.16e-06 |
2.63e-05 |
737 |
REGULATION OF ADAPTIVE IMMUNE RESPONSE |
14 |
123 |
4.268e-06 |
2.694e-05 |
738 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
9 |
49 |
4.389e-06 |
2.767e-05 |
739 |
RESPONSE TO PLATELET DERIVED GROWTH FACTOR |
6 |
18 |
4.463e-06 |
2.81e-05 |
740 |
RESPONSE TO RETINOIC ACID |
13 |
107 |
4.527e-06 |
2.846e-05 |
741 |
DETECTION OF BIOTIC STIMULUS |
7 |
27 |
4.585e-06 |
2.875e-05 |
742 |
REGULATION OF CATENIN IMPORT INTO NUCLEUS |
7 |
27 |
4.585e-06 |
2.875e-05 |
743 |
POSITIVE REGULATION OF HAIR CYCLE |
5 |
11 |
4.911e-06 |
3.075e-05 |
744 |
REGULATION OF CELL CYCLE ARREST |
13 |
108 |
5.025e-06 |
3.143e-05 |
745 |
REGULATION OF BMP SIGNALING PATHWAY |
11 |
77 |
5.037e-06 |
3.146e-05 |
746 |
REGULATION OF MUSCLE ADAPTATION |
10 |
63 |
5.14e-06 |
3.206e-05 |
747 |
LYMPHOCYTE CHEMOTAXIS |
8 |
38 |
5.15e-06 |
3.208e-05 |
748 |
ENDODERM FORMATION |
9 |
50 |
5.229e-06 |
3.253e-05 |
749 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
15 |
143 |
5.421e-06 |
3.368e-05 |
750 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
27 |
393 |
5.675e-06 |
3.516e-05 |
751 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
14 |
126 |
5.673e-06 |
3.516e-05 |
752 |
MITOTIC CELL CYCLE |
42 |
766 |
5.698e-06 |
3.525e-05 |
753 |
POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
10 |
64 |
5.951e-06 |
3.677e-05 |
754 |
RESPONSE TO COPPER ION |
7 |
28 |
5.976e-06 |
3.683e-05 |
755 |
POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE |
7 |
28 |
5.976e-06 |
3.683e-05 |
756 |
SECRETION |
35 |
588 |
6.147e-06 |
3.783e-05 |
757 |
ARTERY MORPHOGENESIS |
9 |
51 |
6.204e-06 |
3.813e-05 |
758 |
POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
8 |
39 |
6.331e-06 |
3.876e-05 |
759 |
REGULATION OF GRANULOCYTE CHEMOTAXIS |
8 |
39 |
6.331e-06 |
3.876e-05 |
760 |
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
8 |
39 |
6.331e-06 |
3.876e-05 |
761 |
DETECTION OF OTHER ORGANISM |
6 |
19 |
6.378e-06 |
3.895e-05 |
762 |
REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS |
6 |
19 |
6.378e-06 |
3.895e-05 |
763 |
REGULATION OF RESPONSE TO OXIDATIVE STRESS |
10 |
65 |
6.87e-06 |
4.189e-05 |
764 |
REGULATION OF MICROTUBULE BASED PROCESS |
20 |
243 |
6.881e-06 |
4.191e-05 |
765 |
ACTIVATION OF MAPKK ACTIVITY |
9 |
52 |
7.33e-06 |
4.458e-05 |
766 |
REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION |
7 |
29 |
7.701e-06 |
4.678e-05 |
767 |
MAMMARY GLAND MORPHOGENESIS |
8 |
40 |
7.734e-06 |
4.692e-05 |
768 |
NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION |
12 |
96 |
7.811e-06 |
4.733e-05 |
769 |
CELL JUNCTION ORGANIZATION |
17 |
185 |
7.913e-06 |
4.782e-05 |
770 |
REGULATION OF VASOCONSTRICTION |
10 |
66 |
7.909e-06 |
4.782e-05 |
771 |
REGULATION OF EPITHELIAL CELL MIGRATION |
16 |
166 |
7.95e-06 |
4.798e-05 |
772 |
RESPONSE TO TEMPERATURE STIMULUS |
15 |
148 |
8.271e-06 |
4.985e-05 |
773 |
OVULATION CYCLE |
13 |
113 |
8.318e-06 |
5.007e-05 |
774 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
9 |
53 |
8.626e-06 |
5.172e-05 |
775 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
9 |
53 |
8.626e-06 |
5.172e-05 |
776 |
MESONEPHRIC TUBULE MORPHOGENESIS |
9 |
53 |
8.626e-06 |
5.172e-05 |
777 |
REGULATION OF INTERFERON GAMMA PRODUCTION |
12 |
97 |
8.706e-06 |
5.213e-05 |
778 |
POSITIVE REGULATION OF CELL CYCLE PROCESS |
20 |
247 |
8.776e-06 |
5.249e-05 |
779 |
ACTIN FILAMENT BASED PROCESS |
29 |
450 |
8.845e-06 |
5.283e-05 |
780 |
NEGATIVE REGULATION OF BINDING |
14 |
131 |
8.943e-06 |
5.335e-05 |
781 |
MACROMOLECULAR COMPLEX ASSEMBLY |
64 |
1398 |
8.964e-06 |
5.341e-05 |
782 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
23 |
312 |
9.008e-06 |
5.36e-05 |
783 |
REGULATION OF AXONOGENESIS |
16 |
168 |
9.263e-06 |
5.504e-05 |
784 |
RECEPTOR METABOLIC PROCESS |
11 |
82 |
9.382e-06 |
5.561e-05 |
785 |
INTEGRIN MEDIATED SIGNALING PATHWAY |
11 |
82 |
9.382e-06 |
5.561e-05 |
786 |
B CELL ACTIVATION |
14 |
132 |
9.768e-06 |
5.783e-05 |
787 |
NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
7 |
30 |
9.819e-06 |
5.783e-05 |
788 |
POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION |
7 |
30 |
9.819e-06 |
5.783e-05 |
789 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
7 |
30 |
9.819e-06 |
5.783e-05 |
790 |
OSTEOCLAST DIFFERENTIATION |
7 |
30 |
9.819e-06 |
5.783e-05 |
791 |
LEUKOCYTE MEDIATED IMMUNITY |
17 |
189 |
1.051e-05 |
6.183e-05 |
792 |
REGULATION OF LIPASE ACTIVITY |
11 |
83 |
1.056e-05 |
6.206e-05 |
793 |
REGULATION OF CELL DIVISION |
21 |
272 |
1.094e-05 |
6.413e-05 |
794 |
MULTICELLULAR ORGANISMAL HOMEOSTASIS |
21 |
272 |
1.094e-05 |
6.413e-05 |
795 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
13 |
116 |
1.11e-05 |
6.489e-05 |
796 |
RESPONSE TO FIBROBLAST GROWTH FACTOR |
13 |
116 |
1.11e-05 |
6.489e-05 |
797 |
LIPID MODIFICATION |
18 |
210 |
1.133e-05 |
6.602e-05 |
798 |
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
8 |
42 |
1.134e-05 |
6.602e-05 |
799 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
8 |
42 |
1.134e-05 |
6.602e-05 |
800 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY |
15 |
152 |
1.144e-05 |
6.653e-05 |
801 |
REGULATION OF BLOOD CIRCULATION |
22 |
295 |
1.173e-05 |
6.817e-05 |
802 |
SINGLE ORGANISM CELLULAR LOCALIZATION |
46 |
898 |
1.189e-05 |
6.896e-05 |
803 |
B CELL HOMEOSTASIS |
6 |
21 |
1.22e-05 |
7.069e-05 |
804 |
TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER |
15 |
153 |
1.238e-05 |
7.166e-05 |
805 |
REGULATION OF CELL SIZE |
16 |
172 |
1.248e-05 |
7.214e-05 |
806 |
PROTEIN AUTOPHOSPHORYLATION |
17 |
192 |
1.294e-05 |
7.468e-05 |
807 |
CARDIOBLAST DIFFERENTIATION |
5 |
13 |
1.31e-05 |
7.533e-05 |
808 |
ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
5 |
13 |
1.31e-05 |
7.533e-05 |
809 |
NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
5 |
13 |
1.31e-05 |
7.533e-05 |
810 |
POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY |
11 |
85 |
1.332e-05 |
7.651e-05 |
811 |
MESODERM DEVELOPMENT |
13 |
118 |
1.338e-05 |
7.678e-05 |
812 |
REGULATION OF CELL SUBSTRATE ADHESION |
16 |
173 |
1.343e-05 |
7.694e-05 |
813 |
DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM |
8 |
43 |
1.361e-05 |
7.79e-05 |
814 |
REGULATION OF CELL CYCLE PHASE TRANSITION |
23 |
321 |
1.427e-05 |
8.154e-05 |
815 |
REGULATION OF PEPTIDE TRANSPORT |
20 |
256 |
1.486e-05 |
8.485e-05 |
816 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
25 |
368 |
1.52e-05 |
8.666e-05 |
817 |
ENDODERM DEVELOPMENT |
10 |
71 |
1.54e-05 |
8.769e-05 |
818 |
ENDOCARDIAL CUSHION DEVELOPMENT |
7 |
32 |
1.551e-05 |
8.792e-05 |
819 |
PATTERNING OF BLOOD VESSELS |
7 |
32 |
1.551e-05 |
8.792e-05 |
820 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND |
7 |
32 |
1.551e-05 |
8.792e-05 |
821 |
NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND |
7 |
32 |
1.551e-05 |
8.792e-05 |
822 |
IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
23 |
323 |
1.576e-05 |
8.92e-05 |
823 |
REGULATION OF CIRCADIAN RHYTHM |
12 |
103 |
1.62e-05 |
9.156e-05 |
824 |
CHROMATIN MODIFICATION |
32 |
539 |
1.621e-05 |
9.156e-05 |
825 |
POSITIVE REGULATION OF MUSCLE CONTRACTION |
8 |
44 |
1.626e-05 |
9.158e-05 |
826 |
NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION |
8 |
44 |
1.626e-05 |
9.158e-05 |
827 |
NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
6 |
22 |
1.64e-05 |
9.185e-05 |
828 |
REGULATION OF HAIR CYCLE |
6 |
22 |
1.64e-05 |
9.185e-05 |
829 |
REGULATION OF INTERLEUKIN 17 PRODUCTION |
6 |
22 |
1.64e-05 |
9.185e-05 |
830 |
REGULATION OF CELLULAR RESPIRATION |
6 |
22 |
1.64e-05 |
9.185e-05 |
831 |
CELLULAR RESPONSE TO INTERLEUKIN 6 |
6 |
22 |
1.64e-05 |
9.185e-05 |
832 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
18 |
216 |
1.663e-05 |
9.302e-05 |
833 |
ENDOTHELIAL CELL DIFFERENTIATION |
10 |
72 |
1.747e-05 |
9.745e-05 |
834 |
DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM |
10 |
72 |
1.747e-05 |
9.745e-05 |
835 |
POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS |
9 |
58 |
1.846e-05 |
0.0001028 |
836 |
MUSCLE SYSTEM PROCESS |
21 |
282 |
1.888e-05 |
0.0001051 |
837 |
DENDRITIC CELL DIFFERENTIATION |
7 |
33 |
1.925e-05 |
0.0001065 |
838 |
RESPONSE TO VITAMIN D |
7 |
33 |
1.925e-05 |
0.0001065 |
839 |
NEGATIVE REGULATION OF JNK CASCADE |
7 |
33 |
1.925e-05 |
0.0001065 |
840 |
RESPONSE TO DEXAMETHASONE |
7 |
33 |
1.925e-05 |
0.0001065 |
841 |
REGULATION OF CELL AGING |
7 |
33 |
1.925e-05 |
0.0001065 |
842 |
NEGATIVE REGULATION OF MAP KINASE ACTIVITY |
10 |
73 |
1.977e-05 |
0.0001093 |
843 |
REGULATION OF PODOSOME ASSEMBLY |
5 |
14 |
1.993e-05 |
0.0001096 |
844 |
CRANIOFACIAL SUTURE MORPHOGENESIS |
5 |
14 |
1.993e-05 |
0.0001096 |
845 |
REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY |
5 |
14 |
1.993e-05 |
0.0001096 |
846 |
POST EMBRYONIC ORGAN DEVELOPMENT |
5 |
14 |
1.993e-05 |
0.0001096 |
847 |
REGULATION OF NUCLEASE ACTIVITY |
6 |
23 |
2.17e-05 |
0.0001186 |
848 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
6 |
23 |
2.17e-05 |
0.0001186 |
849 |
INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY |
12 |
106 |
2.172e-05 |
0.0001186 |
850 |
REGULATION OF METANEPHROS DEVELOPMENT |
6 |
23 |
2.17e-05 |
0.0001186 |
851 |
POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS |
6 |
23 |
2.17e-05 |
0.0001186 |
852 |
NEUROTROPHIN SIGNALING PATHWAY |
6 |
23 |
2.17e-05 |
0.0001186 |
853 |
ANATOMICAL STRUCTURE HOMEOSTASIS |
21 |
285 |
2.21e-05 |
0.0001206 |
854 |
REGULATION OF ACUTE INFLAMMATORY RESPONSE |
10 |
74 |
2.233e-05 |
0.0001215 |
855 |
REGULATION OF STEROID METABOLIC PROCESS |
10 |
74 |
2.233e-05 |
0.0001215 |
856 |
EPIDERMAL CELL DIFFERENTIATION |
14 |
142 |
2.253e-05 |
0.0001225 |
857 |
REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH |
8 |
46 |
2.286e-05 |
0.000124 |
858 |
EMBRYONIC CRANIAL SKELETON MORPHOGENESIS |
8 |
46 |
2.286e-05 |
0.000124 |
859 |
ENDOTHELIUM DEVELOPMENT |
11 |
90 |
2.309e-05 |
0.0001251 |
860 |
RESPONSE TO FLUID SHEAR STRESS |
7 |
34 |
2.37e-05 |
0.0001278 |
861 |
T CELL HOMEOSTASIS |
7 |
34 |
2.37e-05 |
0.0001278 |
862 |
HEART VALVE DEVELOPMENT |
7 |
34 |
2.37e-05 |
0.0001278 |
863 |
CELLULAR RESPONSE TO ALKALOID |
7 |
34 |
2.37e-05 |
0.0001278 |
864 |
REGULATION OF MONOOXYGENASE ACTIVITY |
9 |
60 |
2.446e-05 |
0.0001317 |
865 |
CHROMOSOME ORGANIZATION |
49 |
1009 |
2.486e-05 |
0.0001337 |
866 |
DNA TEMPLATED TRANSCRIPTION INITIATION |
17 |
202 |
2.503e-05 |
0.0001345 |
867 |
GRANULOCYTE MIGRATION |
10 |
75 |
2.517e-05 |
0.0001349 |
868 |
CELLULAR GLUCOSE HOMEOSTASIS |
10 |
75 |
2.517e-05 |
0.0001349 |
869 |
SEX DIFFERENTIATION |
20 |
266 |
2.587e-05 |
0.0001385 |
870 |
NEGATIVE REGULATION OF PROTEIN SECRETION |
12 |
108 |
2.625e-05 |
0.0001402 |
871 |
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
12 |
108 |
2.625e-05 |
0.0001402 |
872 |
CARDIAC CHAMBER DEVELOPMENT |
14 |
144 |
2.638e-05 |
0.0001408 |
873 |
REGULATION OF IMMUNOGLOBULIN PRODUCTION |
8 |
47 |
2.692e-05 |
0.0001435 |
874 |
MONOCARBOXYLIC ACID METABOLIC PROCESS |
30 |
503 |
2.733e-05 |
0.0001455 |
875 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
9 |
61 |
2.803e-05 |
0.0001491 |
876 |
POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION |
6 |
24 |
2.83e-05 |
0.0001494 |
877 |
CELL SUBSTRATE ADHESION |
15 |
164 |
2.832e-05 |
0.0001494 |
878 |
POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION |
6 |
24 |
2.83e-05 |
0.0001494 |
879 |
POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS |
6 |
24 |
2.83e-05 |
0.0001494 |
880 |
NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION |
6 |
24 |
2.83e-05 |
0.0001494 |
881 |
REGULATION OF ISOTYPE SWITCHING |
6 |
24 |
2.83e-05 |
0.0001494 |
882 |
REGULATION OF ANOIKIS |
6 |
24 |
2.83e-05 |
0.0001494 |
883 |
POSITIVE REGULATION OF VASOCONSTRICTION |
7 |
35 |
2.895e-05 |
0.0001522 |
884 |
BONE REMODELING |
7 |
35 |
2.895e-05 |
0.0001522 |
885 |
LIPID METABOLIC PROCESS |
54 |
1158 |
2.891e-05 |
0.0001522 |
886 |
POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION |
5 |
15 |
2.926e-05 |
0.0001525 |
887 |
REGULATION OF HAIR FOLLICLE DEVELOPMENT |
5 |
15 |
2.926e-05 |
0.0001525 |
888 |
NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION |
5 |
15 |
2.926e-05 |
0.0001525 |
889 |
NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION |
5 |
15 |
2.926e-05 |
0.0001525 |
890 |
CHRONIC INFLAMMATORY RESPONSE |
5 |
15 |
2.926e-05 |
0.0001525 |
891 |
POSITIVE REGULATION OF NUCLEASE ACTIVITY |
5 |
15 |
2.926e-05 |
0.0001525 |
892 |
POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS |
5 |
15 |
2.926e-05 |
0.0001525 |
893 |
T CELL APOPTOTIC PROCESS |
5 |
15 |
2.926e-05 |
0.0001525 |
894 |
NEGATIVE REGULATION OF ION TRANSPORT |
13 |
127 |
2.955e-05 |
0.0001538 |
895 |
REGULATION OF MYOBLAST DIFFERENTIATION |
8 |
48 |
3.158e-05 |
0.000164 |
896 |
POSITIVE REGULATION OF WOUND HEALING |
8 |
48 |
3.158e-05 |
0.000164 |
897 |
FOREBRAIN CELL MIGRATION |
9 |
62 |
3.204e-05 |
0.000166 |
898 |
CARDIAC VENTRICLE MORPHOGENESIS |
9 |
62 |
3.204e-05 |
0.000166 |
899 |
POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION |
7 |
36 |
3.514e-05 |
0.0001817 |
900 |
DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE |
7 |
36 |
3.514e-05 |
0.0001817 |
901 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION |
6 |
25 |
3.642e-05 |
0.0001881 |
902 |
REGULATION OF OSTEOCLAST DIFFERENTIATION |
9 |
63 |
3.653e-05 |
0.0001882 |
903 |
RESPONSE TO OSMOTIC STRESS |
9 |
63 |
3.653e-05 |
0.0001882 |
904 |
REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY |
8 |
49 |
3.688e-05 |
0.0001898 |
905 |
COGNITION |
19 |
251 |
3.736e-05 |
0.0001921 |
906 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
28 |
462 |
3.808e-05 |
0.0001956 |
907 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
17 |
209 |
3.866e-05 |
0.0001983 |
908 |
NEGATIVE REGULATION OF PROTEIN BINDING |
10 |
79 |
3.985e-05 |
0.0002042 |
909 |
CATABOLIC PROCESS |
74 |
1773 |
4.063e-05 |
0.000208 |
910 |
RECEPTOR MEDIATED ENDOCYTOSIS |
18 |
231 |
4.075e-05 |
0.0002083 |
911 |
REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS |
5 |
16 |
4.164e-05 |
0.000212 |
912 |
REGULATION OF MONONUCLEAR CELL MIGRATION |
5 |
16 |
4.164e-05 |
0.000212 |
913 |
APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS |
5 |
16 |
4.164e-05 |
0.000212 |
914 |
REGULATION OF INTERLEUKIN 6 BIOSYNTHETIC PROCESS |
5 |
16 |
4.164e-05 |
0.000212 |
915 |
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
7 |
37 |
4.237e-05 |
0.0002154 |
916 |
SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE |
11 |
96 |
4.25e-05 |
0.0002159 |
917 |
PHAGOCYTOSIS |
16 |
190 |
4.275e-05 |
0.0002169 |
918 |
CELLULAR RESPONSE TO CAMP |
8 |
50 |
4.291e-05 |
0.0002175 |
919 |
REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
17 |
211 |
4.36e-05 |
0.0002208 |
920 |
FATTY ACID BIOSYNTHETIC PROCESS |
12 |
114 |
4.512e-05 |
0.0002282 |
921 |
REGULATION OF CELLULAR SENESCENCE |
6 |
26 |
4.63e-05 |
0.0002331 |
922 |
NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
6 |
26 |
4.63e-05 |
0.0002331 |
923 |
CELL CYCLE PHASE TRANSITION |
19 |
255 |
4.633e-05 |
0.0002331 |
924 |
NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT |
6 |
26 |
4.63e-05 |
0.0002331 |
925 |
RESPONSE TO INTERLEUKIN 6 |
6 |
26 |
4.63e-05 |
0.0002331 |
926 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
14 |
152 |
4.815e-05 |
0.000242 |
927 |
MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS |
15 |
172 |
4.933e-05 |
0.0002476 |
928 |
REGULATION OF JUN KINASE ACTIVITY |
10 |
81 |
4.958e-05 |
0.0002486 |
929 |
POSITIVE REGULATION OF FAT CELL DIFFERENTIATION |
8 |
51 |
4.974e-05 |
0.0002491 |
930 |
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
7 |
38 |
5.077e-05 |
0.0002537 |
931 |
MESENCHYME MORPHOGENESIS |
7 |
38 |
5.077e-05 |
0.0002537 |
932 |
MYELOID LEUKOCYTE ACTIVATION |
11 |
98 |
5.152e-05 |
0.0002572 |
933 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
9 |
66 |
5.329e-05 |
0.0002652 |
934 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
9 |
66 |
5.329e-05 |
0.0002652 |
935 |
POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS |
9 |
66 |
5.329e-05 |
0.0002652 |
936 |
RESPONSE TO LIGHT STIMULUS |
20 |
280 |
5.344e-05 |
0.0002656 |
937 |
CELL CYCLE CHECKPOINT |
16 |
194 |
5.496e-05 |
0.0002729 |
938 |
REGULATION OF PROTEIN MATURATION |
10 |
82 |
5.517e-05 |
0.0002737 |
939 |
NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS |
5 |
17 |
5.773e-05 |
0.0002854 |
940 |
MEMBRANE RAFT ORGANIZATION |
5 |
17 |
5.773e-05 |
0.0002854 |
941 |
REGULATION OF RECEPTOR BINDING |
5 |
17 |
5.773e-05 |
0.0002854 |
942 |
SKELETAL MUSCLE TISSUE REGENERATION |
6 |
27 |
5.822e-05 |
0.000287 |
943 |
POSITIVE REGULATION OF HEART GROWTH |
6 |
27 |
5.822e-05 |
0.000287 |
944 |
AXIS ELONGATION |
6 |
27 |
5.822e-05 |
0.000287 |
945 |
PEPTIDYL TYROSINE AUTOPHOSPHORYLATION |
7 |
39 |
6.049e-05 |
0.0002975 |
946 |
PLATELET AGGREGATION |
7 |
39 |
6.049e-05 |
0.0002975 |
947 |
NIK NF KAPPAB SIGNALING |
10 |
83 |
6.128e-05 |
0.0003011 |
948 |
NEGATIVE REGULATION OF INFLAMMATORY RESPONSE |
11 |
100 |
6.214e-05 |
0.0003047 |
949 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
11 |
100 |
6.214e-05 |
0.0003047 |
950 |
SMALL MOLECULE METABOLIC PROCESS |
73 |
1767 |
6.39e-05 |
0.0003126 |
951 |
REGULATION OF LEUKOCYTE MEDIATED IMMUNITY |
14 |
156 |
6.402e-05 |
0.0003126 |
952 |
PROTEIN LOCALIZATION TO NUCLEUS |
14 |
156 |
6.402e-05 |
0.0003126 |
953 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
26 |
426 |
6.383e-05 |
0.0003126 |
954 |
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
8 |
53 |
6.613e-05 |
0.0003225 |
955 |
REGULATION OF CELL JUNCTION ASSEMBLY |
9 |
68 |
6.774e-05 |
0.0003293 |
956 |
REGULATION OF NEUROLOGICAL SYSTEM PROCESS |
9 |
68 |
6.774e-05 |
0.0003293 |
957 |
POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
9 |
68 |
6.774e-05 |
0.0003293 |
958 |
CAMERA TYPE EYE MORPHOGENESIS |
11 |
101 |
6.811e-05 |
0.0003308 |
959 |
NEGATIVE REGULATION OF LOCOMOTION |
19 |
263 |
7.021e-05 |
0.0003407 |
960 |
CELL CYCLE G2 M PHASE TRANSITION |
13 |
138 |
7.061e-05 |
0.0003422 |
961 |
RESPONSE TO CADMIUM ION |
7 |
40 |
7.168e-05 |
0.0003471 |
962 |
REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
6 |
28 |
7.247e-05 |
0.0003491 |
963 |
POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA |
6 |
28 |
7.247e-05 |
0.0003491 |
964 |
REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION |
6 |
28 |
7.247e-05 |
0.0003491 |
965 |
NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS |
6 |
28 |
7.247e-05 |
0.0003491 |
966 |
MAMMARY GLAND DUCT MORPHOGENESIS |
6 |
28 |
7.247e-05 |
0.0003491 |
967 |
CHROMATIN ORGANIZATION |
35 |
663 |
7.442e-05 |
0.0003581 |
968 |
PALATE DEVELOPMENT |
10 |
85 |
7.524e-05 |
0.0003617 |
969 |
NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION |
9 |
69 |
7.612e-05 |
0.000364 |
970 |
REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS |
8 |
54 |
7.587e-05 |
0.000364 |
971 |
POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY |
9 |
69 |
7.612e-05 |
0.000364 |
972 |
MITOTIC CELL CYCLE CHECKPOINT |
13 |
139 |
7.607e-05 |
0.000364 |
973 |
REGULATION OF CELL SHAPE |
13 |
139 |
7.607e-05 |
0.000364 |
974 |
NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION |
5 |
18 |
7.821e-05 |
0.0003714 |
975 |
SMOOTH MUSCLE TISSUE DEVELOPMENT |
5 |
18 |
7.821e-05 |
0.0003714 |
976 |
CELLULAR LIPID METABOLIC PROCESS |
44 |
913 |
7.78e-05 |
0.0003714 |
977 |
PHARYNGEAL SYSTEM DEVELOPMENT |
5 |
18 |
7.821e-05 |
0.0003714 |
978 |
LYMPHOCYTE APOPTOTIC PROCESS |
5 |
18 |
7.821e-05 |
0.0003714 |
979 |
MUSCLE CELL MIGRATION |
5 |
18 |
7.821e-05 |
0.0003714 |
980 |
RESPONSE TO WATER |
5 |
18 |
7.821e-05 |
0.0003714 |
981 |
NEGATIVE REGULATION OF IMMUNE RESPONSE |
12 |
121 |
8.104e-05 |
0.0003844 |
982 |
POSITIVE REGULATION OF B CELL ACTIVATION |
10 |
86 |
8.318e-05 |
0.0003941 |
983 |
NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY |
7 |
41 |
8.451e-05 |
0.0003992 |
984 |
REGULATION OF B CELL MEDIATED IMMUNITY |
7 |
41 |
8.451e-05 |
0.0003992 |
985 |
PROSTATE GLAND DEVELOPMENT |
7 |
41 |
8.451e-05 |
0.0003992 |
986 |
I KAPPAB KINASE NF KAPPAB SIGNALING |
9 |
70 |
8.535e-05 |
0.0004028 |
987 |
EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
8 |
55 |
8.677e-05 |
0.0004084 |
988 |
VIRAL LIFE CYCLE |
20 |
290 |
8.68e-05 |
0.0004084 |
989 |
REGULATION OF MYOTUBE DIFFERENTIATION |
8 |
55 |
8.677e-05 |
0.0004084 |
990 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
12 |
122 |
8.778e-05 |
0.0004126 |
991 |
REGULATION OF CELLULAR COMPONENT SIZE |
22 |
337 |
8.795e-05 |
0.000413 |
992 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
11 |
104 |
8.908e-05 |
0.0004178 |
993 |
NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
6 |
29 |
8.936e-05 |
0.0004183 |
994 |
POSITIVE REGULATION OF CARTILAGE DEVELOPMENT |
6 |
29 |
8.936e-05 |
0.0004183 |
995 |
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION |
16 |
203 |
9.423e-05 |
0.0004406 |
996 |
REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
14 |
162 |
9.632e-05 |
0.00045 |
997 |
REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS |
7 |
42 |
9.914e-05 |
0.0004622 |
998 |
EPITHELIAL CELL MORPHOGENESIS |
7 |
42 |
9.914e-05 |
0.0004622 |
999 |
RAS PROTEIN SIGNAL TRANSDUCTION |
13 |
143 |
0.0001017 |
0.0004738 |
1000 |
NEGATIVE REGULATION OF HOMEOSTATIC PROCESS |
12 |
124 |
0.0001027 |
0.000478 |
1001 |
RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN |
14 |
163 |
0.0001029 |
0.0004783 |
1002 |
VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION |
5 |
19 |
0.0001039 |
0.0004785 |
1003 |
FIBRIL ORGANIZATION |
5 |
19 |
0.0001039 |
0.0004785 |
1004 |
REGULATION OF WATER LOSS VIA SKIN |
5 |
19 |
0.0001039 |
0.0004785 |
1005 |
MUSCLE CELL PROLIFERATION |
5 |
19 |
0.0001039 |
0.0004785 |
1006 |
ORGANIC ACID METABOLIC PROCESS |
45 |
953 |
0.0001032 |
0.0004785 |
1007 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
5 |
19 |
0.0001039 |
0.0004785 |
1008 |
REGULATION OF INTERLEUKIN 8 SECRETION |
5 |
19 |
0.0001039 |
0.0004785 |
1009 |
MACROPHAGE DIFFERENTIATION |
5 |
19 |
0.0001039 |
0.0004785 |
1010 |
POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION |
5 |
19 |
0.0001039 |
0.0004785 |
1011 |
SEXUAL REPRODUCTION |
37 |
730 |
0.0001071 |
0.0004931 |
1012 |
SMOOTH MUSCLE CELL DIFFERENTIATION |
6 |
30 |
0.0001092 |
0.0005023 |
1013 |
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY |
10 |
89 |
0.0001114 |
0.0005116 |
1014 |
CELL FATE DETERMINATION |
7 |
43 |
0.0001158 |
0.0005313 |
1015 |
SYNAPSE ORGANIZATION |
13 |
145 |
0.0001172 |
0.0005371 |
1016 |
POSITIVE REGULATION OF PROTEIN BINDING |
9 |
73 |
0.0001189 |
0.0005438 |
1017 |
PANCREAS DEVELOPMENT |
9 |
73 |
0.0001189 |
0.0005438 |
1018 |
RESPONSE TO UV |
12 |
126 |
0.0001198 |
0.0005477 |
1019 |
PATTERN SPECIFICATION PROCESS |
25 |
418 |
0.0001209 |
0.0005521 |
1020 |
CALCIUM MEDIATED SIGNALING |
10 |
90 |
0.0001224 |
0.0005573 |
1021 |
REGULATION OF CELL MATRIX ADHESION |
10 |
90 |
0.0001224 |
0.0005573 |
1022 |
REGULATION OF GLIOGENESIS |
10 |
90 |
0.0001224 |
0.0005573 |
1023 |
COVALENT CHROMATIN MODIFICATION |
22 |
345 |
0.0001235 |
0.0005617 |
1024 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
13 |
146 |
0.0001256 |
0.0005696 |
1025 |
NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
13 |
146 |
0.0001256 |
0.0005696 |
1026 |
DNA INTEGRITY CHECKPOINT |
13 |
146 |
0.0001256 |
0.0005696 |
1027 |
REGULATION OF MULTI ORGANISM PROCESS |
27 |
470 |
0.0001276 |
0.0005781 |
1028 |
RESPONSE TO INTERLEUKIN 4 |
6 |
31 |
0.0001325 |
0.0005958 |
1029 |
POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
4 |
11 |
0.0001328 |
0.0005958 |
1030 |
REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION |
6 |
31 |
0.0001325 |
0.0005958 |
1031 |
CARDIAC CELL FATE COMMITMENT |
4 |
11 |
0.0001328 |
0.0005958 |
1032 |
DETECTION OF MOLECULE OF BACTERIAL ORIGIN |
4 |
11 |
0.0001328 |
0.0005958 |
1033 |
POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS |
4 |
11 |
0.0001328 |
0.0005958 |
1034 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION |
6 |
31 |
0.0001325 |
0.0005958 |
1035 |
LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE |
4 |
11 |
0.0001328 |
0.0005958 |
1036 |
NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION |
4 |
11 |
0.0001328 |
0.0005958 |
1037 |
REGULATION OF NECROPTOTIC PROCESS |
4 |
11 |
0.0001328 |
0.0005958 |
1038 |
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
13 |
147 |
0.0001346 |
0.0006028 |
1039 |
REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA |
7 |
44 |
0.0001346 |
0.0006028 |
1040 |
RESPONSE TO PROTOZOAN |
5 |
20 |
0.0001355 |
0.0006046 |
1041 |
RESPONSE TO LIPOPROTEIN PARTICLE |
5 |
20 |
0.0001355 |
0.0006046 |
1042 |
NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION |
5 |
20 |
0.0001355 |
0.0006046 |
1043 |
MYELOID DENDRITIC CELL DIFFERENTIATION |
5 |
20 |
0.0001355 |
0.0006046 |
1044 |
NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
11 |
109 |
0.0001363 |
0.0006069 |
1045 |
UNSATURATED FATTY ACID METABOLIC PROCESS |
11 |
109 |
0.0001363 |
0.0006069 |
1046 |
NEGATIVE REGULATION OF HEMOPOIESIS |
12 |
128 |
0.0001393 |
0.000619 |
1047 |
MUSCLE CELL DEVELOPMENT |
12 |
128 |
0.0001393 |
0.000619 |
1048 |
POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION |
26 |
448 |
0.0001441 |
0.000639 |
1049 |
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
8 |
59 |
0.0001442 |
0.000639 |
1050 |
VASCULOGENESIS |
8 |
59 |
0.0001442 |
0.000639 |
1051 |
REGULATION OF CHROMOSOME ORGANIZATION |
19 |
278 |
0.0001456 |
0.0006447 |
1052 |
MITOCHONDRIAL MEMBRANE ORGANIZATION |
10 |
92 |
0.0001473 |
0.0006514 |
1053 |
CELL PART MORPHOGENESIS |
33 |
633 |
0.0001503 |
0.0006643 |
1054 |
CELLULAR MACROMOLECULE LOCALIZATION |
54 |
1234 |
0.0001522 |
0.0006721 |
1055 |
THYMOCYTE AGGREGATION |
7 |
45 |
0.0001558 |
0.0006834 |
1056 |
SPROUTING ANGIOGENESIS |
7 |
45 |
0.0001558 |
0.0006834 |
1057 |
REGULATION OF EPIDERMAL CELL DIFFERENTIATION |
7 |
45 |
0.0001558 |
0.0006834 |
1058 |
T CELL DIFFERENTIATION IN THYMUS |
7 |
45 |
0.0001558 |
0.0006834 |
1059 |
HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES |
7 |
45 |
0.0001558 |
0.0006834 |
1060 |
NEGATIVE REGULATION OF CHROMATIN MODIFICATION |
7 |
45 |
0.0001558 |
0.0006834 |
1061 |
ENDOCHONDRAL BONE MORPHOGENESIS |
7 |
45 |
0.0001558 |
0.0006834 |
1062 |
POSITIVE REGULATION OF DENDRITE MORPHOGENESIS |
6 |
32 |
0.0001595 |
0.0006981 |
1063 |
ADIPOSE TISSUE DEVELOPMENT |
6 |
32 |
0.0001595 |
0.0006981 |
1064 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
10 |
93 |
0.0001612 |
0.000705 |
1065 |
REGULATION OF CALCIUM MEDIATED SIGNALING |
9 |
76 |
0.0001628 |
0.0007097 |
1066 |
GLIAL CELL DEVELOPMENT |
9 |
76 |
0.0001628 |
0.0007097 |
1067 |
OLIGODENDROCYTE DIFFERENTIATION |
8 |
60 |
0.0001626 |
0.0007097 |
1068 |
REGULATION OF HORMONE LEVELS |
27 |
478 |
0.0001679 |
0.0007315 |
1069 |
TISSUE HOMEOSTASIS |
14 |
171 |
0.0001711 |
0.0007445 |
1070 |
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT |
12 |
131 |
0.0001735 |
0.0007546 |
1071 |
CELL AGGREGATION |
5 |
21 |
0.0001741 |
0.0007548 |
1072 |
APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT |
5 |
21 |
0.0001741 |
0.0007548 |
1073 |
CARTILAGE CONDENSATION |
5 |
21 |
0.0001741 |
0.0007548 |
1074 |
REGULATION OF CELLULAR AMIDE METABOLIC PROCESS |
22 |
354 |
0.0001782 |
0.0007722 |
1075 |
PEPTIDYL THREONINE MODIFICATION |
7 |
46 |
0.0001797 |
0.0007778 |
1076 |
REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY |
8 |
61 |
0.0001829 |
0.0007911 |
1077 |
REGULATION OF CHROMATIN ORGANIZATION |
13 |
152 |
0.0001881 |
0.0008126 |
1078 |
POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION |
6 |
33 |
0.0001907 |
0.0008206 |
1079 |
SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND |
6 |
33 |
0.0001907 |
0.0008206 |
1080 |
EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND |
6 |
33 |
0.0001907 |
0.0008206 |
1081 |
REGULATION OF INTERLEUKIN 1 SECRETION |
6 |
33 |
0.0001907 |
0.0008206 |
1082 |
POSITIVE REGULATION OF CELLULAR EXTRAVASATION |
4 |
12 |
0.000195 |
0.0008341 |
1083 |
REGULATION OF MACROPHAGE CYTOKINE PRODUCTION |
4 |
12 |
0.000195 |
0.0008341 |
1084 |
POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS |
4 |
12 |
0.000195 |
0.0008341 |
1085 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
4 |
12 |
0.000195 |
0.0008341 |
1086 |
POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS |
4 |
12 |
0.000195 |
0.0008341 |
1087 |
NEGATIVE REGULATION OF RECEPTOR BINDING |
4 |
12 |
0.000195 |
0.0008341 |
1088 |
POSITIVE REGULATION OF CAMP MEDIATED SIGNALING |
4 |
12 |
0.000195 |
0.0008341 |
1089 |
LYMPHOCYTE COSTIMULATION |
9 |
78 |
0.0001989 |
0.00085 |
1090 |
POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS |
12 |
133 |
0.0002002 |
0.0008537 |
1091 |
POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
12 |
133 |
0.0002002 |
0.0008537 |
1092 |
ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY |
15 |
195 |
0.000202 |
0.0008609 |
1093 |
REGULATION OF HORMONE SECRETION |
18 |
262 |
0.0002026 |
0.0008627 |
1094 |
NOTCH SIGNALING PATHWAY |
11 |
114 |
0.0002033 |
0.0008646 |
1095 |
REGULATION OF TISSUE REMODELING |
8 |
62 |
0.0002053 |
0.0008724 |
1096 |
POSITIVE REGULATION OF GLIOGENESIS |
7 |
47 |
0.0002064 |
0.0008764 |
1097 |
PROTEIN LOCALIZATION |
72 |
1805 |
0.0002099 |
0.0008895 |
1098 |
REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
10 |
96 |
0.0002099 |
0.0008895 |
1099 |
POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
15 |
196 |
0.0002136 |
0.0009045 |
1100 |
REGULATION OF MITOCHONDRION ORGANIZATION |
16 |
218 |
0.000215 |
0.0009094 |
1101 |
PROTEIN OLIGOMERIZATION |
25 |
434 |
0.0002157 |
0.0009116 |
1102 |
CELL DIVISION |
26 |
460 |
0.0002185 |
0.0009224 |
1103 |
SECRETION BY CELL |
27 |
486 |
0.0002192 |
0.0009246 |
1104 |
ERBB SIGNALING PATHWAY |
9 |
79 |
0.0002194 |
0.0009246 |
1105 |
CELLULAR RESPONSE TO VIRUS |
5 |
22 |
0.0002204 |
0.0009265 |
1106 |
ENDOCARDIAL CUSHION MORPHOGENESIS |
5 |
22 |
0.0002204 |
0.0009265 |
1107 |
POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT |
5 |
22 |
0.0002204 |
0.0009265 |
1108 |
REGULATION OF CELL KILLING |
8 |
63 |
0.0002298 |
0.0009652 |
1109 |
PEPTIDYL LYSINE MODIFICATION |
20 |
312 |
0.0002314 |
0.000971 |
1110 |
RESPONSE TO AMINE |
7 |
48 |
0.0002363 |
0.0009887 |
1111 |
REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS |
7 |
48 |
0.0002363 |
0.0009887 |
1112 |
REGULATION OF INTERLEUKIN 2 PRODUCTION |
7 |
48 |
0.0002363 |
0.0009887 |
1113 |
NEGATIVE REGULATION OF LIPID METABOLIC PROCESS |
9 |
80 |
0.0002415 |
0.00101 |
1114 |
HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION |
10 |
98 |
0.0002488 |
0.001039 |
1115 |
POSITIVE REGULATION OF DENDRITE DEVELOPMENT |
8 |
64 |
0.0002567 |
0.00107 |
1116 |
POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS |
8 |
64 |
0.0002567 |
0.00107 |
1117 |
REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION |
14 |
178 |
0.0002597 |
0.001082 |
1118 |
CELLULAR RESPONSE TO RADIATION |
12 |
137 |
0.000264 |
0.001099 |
1119 |
NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS |
6 |
35 |
0.0002673 |
0.001106 |
1120 |
NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION |
6 |
35 |
0.0002673 |
0.001106 |
1121 |
POSITIVE REGULATION OF HEART CONTRACTION |
6 |
35 |
0.0002673 |
0.001106 |
1122 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS |
6 |
35 |
0.0002673 |
0.001106 |
1123 |
RESPONSE TO IRON ION |
6 |
35 |
0.0002673 |
0.001106 |
1124 |
B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE |
6 |
35 |
0.0002673 |
0.001106 |
1125 |
ACTIN FILAMENT BUNDLE ORGANIZATION |
7 |
49 |
0.0002695 |
0.001113 |
1126 |
CARDIAC SEPTUM MORPHOGENESIS |
7 |
49 |
0.0002695 |
0.001113 |
1127 |
CARDIAC CELL DEVELOPMENT |
7 |
49 |
0.0002695 |
0.001113 |
1128 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
10 |
99 |
0.0002704 |
0.001114 |
1129 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
10 |
99 |
0.0002704 |
0.001114 |
1130 |
CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS |
4 |
13 |
0.0002759 |
0.001116 |
1131 |
PROSTATE GLAND MORPHOGENESIS |
5 |
23 |
0.0002756 |
0.001116 |
1132 |
WHITE FAT CELL DIFFERENTIATION |
4 |
13 |
0.0002759 |
0.001116 |
1133 |
POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS |
5 |
23 |
0.0002756 |
0.001116 |
1134 |
PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
4 |
13 |
0.0002759 |
0.001116 |
1135 |
REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE |
4 |
13 |
0.0002759 |
0.001116 |
1136 |
POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS |
4 |
13 |
0.0002759 |
0.001116 |
1137 |
HORMONE MEDIATED SIGNALING PATHWAY |
13 |
158 |
0.0002756 |
0.001116 |
1138 |
EYELID DEVELOPMENT IN CAMERA TYPE EYE |
4 |
13 |
0.0002759 |
0.001116 |
1139 |
REGULATION OF CAMP MEDIATED SIGNALING |
5 |
23 |
0.0002756 |
0.001116 |
1140 |
REGULATION OF REGULATORY T CELL DIFFERENTIATION |
4 |
13 |
0.0002759 |
0.001116 |
1141 |
RESPONSE TO AUDITORY STIMULUS |
5 |
23 |
0.0002756 |
0.001116 |
1142 |
TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY |
11 |
118 |
0.0002753 |
0.001116 |
1143 |
POSITIVE REGULATION OF NEUROLOGICAL SYSTEM PROCESS |
5 |
23 |
0.0002756 |
0.001116 |
1144 |
RESPONSE TO PARATHYROID HORMONE |
4 |
13 |
0.0002759 |
0.001116 |
1145 |
NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY |
4 |
13 |
0.0002759 |
0.001116 |
1146 |
RESPONSE TO COBALT ION |
4 |
13 |
0.0002759 |
0.001116 |
1147 |
REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS |
4 |
13 |
0.0002759 |
0.001116 |
1148 |
VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT |
4 |
13 |
0.0002759 |
0.001116 |
1149 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION |
4 |
13 |
0.0002759 |
0.001116 |
1150 |
REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY |
4 |
13 |
0.0002759 |
0.001116 |
1151 |
MAINTENANCE OF LOCATION |
12 |
138 |
0.0002824 |
0.001142 |
1152 |
NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
9 |
82 |
0.0002915 |
0.001177 |
1153 |
METENCEPHALON DEVELOPMENT |
10 |
100 |
0.0002935 |
0.001183 |
1154 |
MITOTIC DNA INTEGRITY CHECKPOINT |
10 |
100 |
0.0002935 |
0.001183 |
1155 |
CELL MATRIX ADHESION |
11 |
119 |
0.0002963 |
0.001193 |
1156 |
POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
11 |
119 |
0.0002963 |
0.001193 |
1157 |
POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
7 |
50 |
0.0003064 |
0.001232 |
1158 |
SECOND MESSENGER MEDIATED SIGNALING |
13 |
160 |
0.0003116 |
0.001252 |
1159 |
NEUROMUSCULAR JUNCTION DEVELOPMENT |
6 |
36 |
0.0003137 |
0.001256 |
1160 |
NEGATIVE REGULATION OF HISTONE MODIFICATION |
6 |
36 |
0.0003137 |
0.001256 |
1161 |
NEGATIVE REGULATION OF BLOOD CIRCULATION |
6 |
36 |
0.0003137 |
0.001256 |
1162 |
CELLULAR RESPONSE TO HEAT |
6 |
36 |
0.0003137 |
0.001256 |
1163 |
REGULATION OF MULTICELLULAR ORGANISM GROWTH |
8 |
66 |
0.0003183 |
0.001271 |
1164 |
KERATINOCYTE DIFFERENTIATION |
10 |
101 |
0.0003183 |
0.001271 |
1165 |
REGULATION OF EXTENT OF CELL GROWTH |
10 |
101 |
0.0003183 |
0.001271 |
1166 |
REGULATION OF DENDRITE DEVELOPMENT |
11 |
120 |
0.0003186 |
0.001272 |
1167 |
NEGATIVE REGULATION OF STEROID METABOLIC PROCESS |
5 |
24 |
0.0003407 |
0.001356 |
1168 |
POSITIVE REGULATION OF INTERLEUKIN 1 SECRETION |
5 |
24 |
0.0003407 |
0.001356 |
1169 |
REGULATION OF ODONTOGENESIS |
5 |
24 |
0.0003407 |
0.001356 |
1170 |
NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS |
10 |
102 |
0.0003448 |
0.001371 |
1171 |
RESPONSE TO AMMONIUM ION |
7 |
51 |
0.0003473 |
0.001374 |
1172 |
POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
7 |
51 |
0.0003473 |
0.001374 |
1173 |
REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
15 |
205 |
0.0003466 |
0.001374 |
1174 |
CELLULAR RESPONSE TO FATTY ACID |
7 |
51 |
0.0003473 |
0.001374 |
1175 |
HOMOTYPIC CELL CELL ADHESION |
7 |
51 |
0.0003473 |
0.001374 |
1176 |
POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION |
7 |
51 |
0.0003473 |
0.001374 |
1177 |
NEURON FATE COMMITMENT |
8 |
67 |
0.0003533 |
0.001397 |
1178 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
14 |
184 |
0.0003646 |
0.00144 |
1179 |
RESPONSE TO NERVE GROWTH FACTOR |
6 |
37 |
0.0003662 |
0.001442 |
1180 |
POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY |
6 |
37 |
0.0003662 |
0.001442 |
1181 |
REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION |
6 |
37 |
0.0003662 |
0.001442 |
1182 |
POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION |
6 |
37 |
0.0003662 |
0.001442 |
1183 |
LOCALIZATION WITHIN MEMBRANE |
11 |
122 |
0.0003676 |
0.001446 |
1184 |
POSITIVE REGULATION OF METANEPHROS DEVELOPMENT |
4 |
14 |
0.0003783 |
0.001477 |
1185 |
LAYER FORMATION IN CEREBRAL CORTEX |
4 |
14 |
0.0003783 |
0.001477 |
1186 |
NEGATIVE REGULATION OF JUN KINASE ACTIVITY |
4 |
14 |
0.0003783 |
0.001477 |
1187 |
ATRIAL SEPTUM MORPHOGENESIS |
4 |
14 |
0.0003783 |
0.001477 |
1188 |
POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE |
4 |
14 |
0.0003783 |
0.001477 |
1189 |
RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE |
4 |
14 |
0.0003783 |
0.001477 |
1190 |
METANEPHRIC MESENCHYME DEVELOPMENT |
4 |
14 |
0.0003783 |
0.001477 |
1191 |
POSITIVE REGULATION OF SPROUTING ANGIOGENESIS |
4 |
14 |
0.0003783 |
0.001477 |
1192 |
REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
4 |
14 |
0.0003783 |
0.001477 |
1193 |
NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE |
7 |
52 |
0.0003923 |
0.001523 |
1194 |
REGULATION OF ALPHA BETA T CELL ACTIVATION |
8 |
68 |
0.0003914 |
0.001523 |
1195 |
NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS |
7 |
52 |
0.0003923 |
0.001523 |
1196 |
NEGATIVE REGULATION OF T CELL PROLIFERATION |
7 |
52 |
0.0003923 |
0.001523 |
1197 |
POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
7 |
52 |
0.0003923 |
0.001523 |
1198 |
RESPONSE TO FUNGUS |
7 |
52 |
0.0003923 |
0.001523 |
1199 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
8 |
68 |
0.0003914 |
0.001523 |
1200 |
LENS FIBER CELL DIFFERENTIATION |
5 |
25 |
0.0004168 |
0.001609 |
1201 |
MEMBRANE ASSEMBLY |
5 |
25 |
0.0004168 |
0.001609 |
1202 |
CELLULAR EXTRAVASATION |
5 |
25 |
0.0004168 |
0.001609 |
1203 |
HISTONE PHOSPHORYLATION |
5 |
25 |
0.0004168 |
0.001609 |
1204 |
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
5 |
25 |
0.0004168 |
0.001609 |
1205 |
THYROID GLAND DEVELOPMENT |
5 |
25 |
0.0004168 |
0.001609 |
1206 |
NEGATIVE REGULATION OF DEFENSE RESPONSE |
12 |
144 |
0.0004174 |
0.00161 |
1207 |
SINGLE ORGANISM CATABOLIC PROCESS |
43 |
957 |
0.0004229 |
0.00163 |
1208 |
POSITIVE REGULATION OF ORGAN GROWTH |
6 |
38 |
0.0004254 |
0.001639 |
1209 |
RESPONSE TO ACTIVITY |
8 |
69 |
0.0004327 |
0.001665 |
1210 |
NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT |
9 |
87 |
0.0004546 |
0.001748 |
1211 |
CARDIAC VENTRICLE DEVELOPMENT |
10 |
106 |
0.0004698 |
0.001805 |
1212 |
POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION |
13 |
167 |
0.0004709 |
0.001808 |
1213 |
T CELL RECEPTOR SIGNALING PATHWAY |
12 |
146 |
0.0004731 |
0.001815 |
1214 |
REGULATION OF MEMBRANE PERMEABILITY |
8 |
70 |
0.0004775 |
0.00183 |
1215 |
REGULATION OF PHOSPHOLIPASE C ACTIVITY |
6 |
39 |
0.0004917 |
0.001879 |
1216 |
TRABECULA MORPHOGENESIS |
6 |
39 |
0.0004917 |
0.001879 |
1217 |
CELLULAR RESPONSE TO NUTRIENT |
6 |
39 |
0.0004917 |
0.001879 |
1218 |
SPLEEN DEVELOPMENT |
6 |
39 |
0.0004917 |
0.001879 |
1219 |
OVULATION CYCLE PROCESS |
9 |
88 |
0.0004949 |
0.001889 |
1220 |
REGULATION OF TYPE 2 IMMUNE RESPONSE |
5 |
26 |
0.000505 |
0.001899 |
1221 |
POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY |
5 |
26 |
0.000505 |
0.001899 |
1222 |
RESPONSE TO MURAMYL DIPEPTIDE |
4 |
15 |
0.0005052 |
0.001899 |
1223 |
REGULATION OF MESONEPHROS DEVELOPMENT |
5 |
26 |
0.000505 |
0.001899 |
1224 |
NEGATIVE REGULATION OF HISTONE ACETYLATION |
4 |
15 |
0.0005052 |
0.001899 |
1225 |
REPLACEMENT OSSIFICATION |
5 |
26 |
0.000505 |
0.001899 |
1226 |
CELLULAR RESPONSE TO INTERLEUKIN 4 |
5 |
26 |
0.000505 |
0.001899 |
1227 |
POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS |
4 |
15 |
0.0005052 |
0.001899 |
1228 |
LYMPHOCYTE MEDIATED IMMUNITY |
12 |
147 |
0.0005032 |
0.001899 |
1229 |
NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY |
5 |
26 |
0.000505 |
0.001899 |
1230 |
JAK STAT CASCADE INVOLVED IN GROWTH HORMONE SIGNALING PATHWAY |
4 |
15 |
0.0005052 |
0.001899 |
1231 |
POSITIVE REGULATION OF IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE |
5 |
26 |
0.000505 |
0.001899 |
1232 |
MESODERMAL CELL DIFFERENTIATION |
5 |
26 |
0.000505 |
0.001899 |
1233 |
MUSCLE CELL FATE COMMITMENT |
4 |
15 |
0.0005052 |
0.001899 |
1234 |
STRIATED MUSCLE CELL PROLIFERATION |
4 |
15 |
0.0005052 |
0.001899 |
1235 |
RESPONSE TO HYDROPEROXIDE |
4 |
15 |
0.0005052 |
0.001899 |
1236 |
ENDOCHONDRAL OSSIFICATION |
5 |
26 |
0.000505 |
0.001899 |
1237 |
CELLULAR RESPONSE TO VITAMIN |
5 |
26 |
0.000505 |
0.001899 |
1238 |
MYELOID DENDRITIC CELL ACTIVATION |
5 |
26 |
0.000505 |
0.001899 |
1239 |
PLATELET DEGRANULATION |
10 |
107 |
0.0005064 |
0.001902 |
1240 |
GAMETE GENERATION |
30 |
595 |
0.0005177 |
0.001943 |
1241 |
SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
11 |
127 |
0.0005185 |
0.001944 |
1242 |
REGULATION OF BLOOD PRESSURE |
13 |
169 |
0.0005274 |
0.001973 |
1243 |
APPENDAGE DEVELOPMENT |
13 |
169 |
0.0005274 |
0.001973 |
1244 |
LIMB DEVELOPMENT |
13 |
169 |
0.0005274 |
0.001973 |
1245 |
MALE SEX DIFFERENTIATION |
12 |
148 |
0.0005348 |
0.001999 |
1246 |
POSITIVE REGULATION OF CAMP METABOLIC PROCESS |
9 |
89 |
0.0005381 |
0.002009 |
1247 |
NEGATIVE REGULATION OF CELL CYCLE PROCESS |
15 |
214 |
0.0005452 |
0.002034 |
1248 |
REGULATION OF PHOSPHATASE ACTIVITY |
11 |
128 |
0.0005541 |
0.002066 |
1249 |
NAD METABOLIC PROCESS |
7 |
55 |
0.0005563 |
0.002071 |
1250 |
NATURAL KILLER CELL ACTIVATION |
7 |
55 |
0.0005563 |
0.002071 |
1251 |
NEGATIVE REGULATION OF CELL GROWTH |
13 |
170 |
0.0005578 |
0.002075 |
1252 |
HINDBRAIN MORPHOGENESIS |
6 |
40 |
0.0005659 |
0.002101 |
1253 |
NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION |
6 |
40 |
0.0005659 |
0.002101 |
1254 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
14 |
193 |
0.000589 |
0.002185 |
1255 |
REGIONALIZATION |
19 |
311 |
0.0005944 |
0.002204 |
1256 |
ORGANOPHOSPHATE METABOLIC PROCESS |
40 |
885 |
0.000597 |
0.002212 |
1257 |
NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE |
5 |
27 |
0.0006065 |
0.002235 |
1258 |
POSITIVE REGULATION OF NEUTROPHIL MIGRATION |
5 |
27 |
0.0006065 |
0.002235 |
1259 |
POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION |
5 |
27 |
0.0006065 |
0.002235 |
1260 |
NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR |
5 |
27 |
0.0006065 |
0.002235 |
1261 |
CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS |
5 |
27 |
0.0006065 |
0.002235 |
1262 |
POSITIVE REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS |
5 |
27 |
0.0006065 |
0.002235 |
1263 |
HETEROTYPIC CELL CELL ADHESION |
5 |
27 |
0.0006065 |
0.002235 |
1264 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
13 |
172 |
0.0006229 |
0.002293 |
1265 |
NEURON MIGRATION |
10 |
110 |
0.0006304 |
0.002319 |
1266 |
HIPPOCAMPUS DEVELOPMENT |
8 |
73 |
0.000635 |
0.002334 |
1267 |
REGULATION OF LIPID STORAGE |
6 |
41 |
0.0006484 |
0.002376 |
1268 |
TRANSLESION SYNTHESIS |
6 |
41 |
0.0006484 |
0.002376 |
1269 |
CELLULAR RESPONSE TO ESTROGEN STIMULUS |
6 |
41 |
0.0006484 |
0.002376 |
1270 |
MONOCYTE CHEMOTAXIS |
6 |
41 |
0.0006484 |
0.002376 |
1271 |
MODULATION OF GROWTH OF SYMBIONT INVOLVED IN INTERACTION WITH HOST |
4 |
16 |
0.0006598 |
0.002406 |
1272 |
CARDIAC MYOFIBRIL ASSEMBLY |
4 |
16 |
0.0006598 |
0.002406 |
1273 |
REGULATION OF MACROPHAGE CHEMOTAXIS |
4 |
16 |
0.0006598 |
0.002406 |
1274 |
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT |
4 |
16 |
0.0006598 |
0.002406 |
1275 |
NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
4 |
16 |
0.0006598 |
0.002406 |
1276 |
MONOCYTE DIFFERENTIATION |
4 |
16 |
0.0006598 |
0.002406 |
1277 |
LEARNING |
11 |
131 |
0.0006735 |
0.002454 |
1278 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
10 |
111 |
0.0006769 |
0.002465 |
1279 |
SMALL MOLECULE BIOSYNTHETIC PROCESS |
24 |
443 |
0.0006887 |
0.002505 |
1280 |
POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
7 |
57 |
0.0006929 |
0.002517 |
1281 |
APOPTOTIC MITOCHONDRIAL CHANGES |
7 |
57 |
0.0006929 |
0.002517 |
1282 |
ACTIN FILAMENT ORGANIZATION |
13 |
174 |
0.0006944 |
0.00252 |
1283 |
REGULATION OF DENDRITE MORPHOGENESIS |
8 |
74 |
0.000696 |
0.002524 |
1284 |
POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS |
5 |
28 |
0.0007226 |
0.002603 |
1285 |
NECROTIC CELL DEATH |
5 |
28 |
0.0007226 |
0.002603 |
1286 |
CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER |
5 |
28 |
0.0007226 |
0.002603 |
1287 |
REGULATION OF NEUROBLAST PROLIFERATION |
5 |
28 |
0.0007226 |
0.002603 |
1288 |
LONG TERM MEMORY |
5 |
28 |
0.0007226 |
0.002603 |
1289 |
T CELL MEDIATED IMMUNITY |
5 |
28 |
0.0007226 |
0.002603 |
1290 |
REGULATION OF SPROUTING ANGIOGENESIS |
5 |
28 |
0.0007226 |
0.002603 |
1291 |
RESPONSE TO GONADOTROPIN |
5 |
28 |
0.0007226 |
0.002603 |
1292 |
POSITIVE REGULATION OF PHOSPHATASE ACTIVITY |
5 |
28 |
0.0007226 |
0.002603 |
1293 |
POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
6 |
42 |
0.0007399 |
0.002661 |
1294 |
REGULATION OF NIK NF KAPPAB SIGNALING |
6 |
42 |
0.0007399 |
0.002661 |
1295 |
REGULATION OF DNA REPAIR |
8 |
75 |
0.0007616 |
0.002734 |
1296 |
ODONTOGENESIS OF DENTIN CONTAINING TOOTH |
8 |
75 |
0.0007616 |
0.002734 |
1297 |
REGULATION OF DNA RECOMBINATION |
7 |
58 |
0.0007705 |
0.002764 |
1298 |
CARBOXYLIC ACID BIOSYNTHETIC PROCESS |
17 |
270 |
0.0008139 |
0.002913 |
1299 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
11 |
134 |
0.0008137 |
0.002913 |
1300 |
ORGANIC ACID BIOSYNTHETIC PROCESS |
17 |
270 |
0.0008139 |
0.002913 |
1301 |
REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY |
10 |
114 |
0.0008338 |
0.00298 |
1302 |
REGULATION OF EMBRYONIC DEVELOPMENT |
10 |
114 |
0.0008338 |
0.00298 |
1303 |
NEGATIVE REGULATION OF KIDNEY DEVELOPMENT |
4 |
17 |
0.000845 |
0.00299 |
1304 |
BRANCH ELONGATION OF AN EPITHELIUM |
4 |
17 |
0.000845 |
0.00299 |
1305 |
POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER |
4 |
17 |
0.000845 |
0.00299 |
1306 |
HEXOSE TRANSMEMBRANE TRANSPORT |
4 |
17 |
0.000845 |
0.00299 |
1307 |
ANATOMICAL STRUCTURE ARRANGEMENT |
4 |
17 |
0.000845 |
0.00299 |
1308 |
NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS |
6 |
43 |
0.0008411 |
0.00299 |
1309 |
NEGATIVE REGULATION OF CELL AGING |
4 |
17 |
0.000845 |
0.00299 |
1310 |
REGULATION OF PLATELET AGGREGATION |
4 |
17 |
0.000845 |
0.00299 |
1311 |
POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION |
4 |
17 |
0.000845 |
0.00299 |
1312 |
MORPHOGENESIS OF AN EPITHELIAL SHEET |
6 |
43 |
0.0008411 |
0.00299 |
1313 |
POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN |
4 |
17 |
0.000845 |
0.00299 |
1314 |
GLUCOSE TRANSMEMBRANE TRANSPORT |
4 |
17 |
0.000845 |
0.00299 |
1315 |
REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
4 |
17 |
0.000845 |
0.00299 |
1316 |
REGULATION OF CELL CYCLE G2 M PHASE TRANSITION |
7 |
59 |
0.0008548 |
0.003013 |
1317 |
STEM CELL DIVISION |
5 |
29 |
0.0008546 |
0.003013 |
1318 |
POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING |
5 |
29 |
0.0008546 |
0.003013 |
1319 |
REGULATION OF THE FORCE OF HEART CONTRACTION |
5 |
29 |
0.0008546 |
0.003013 |
1320 |
MUSCLE ADAPTATION |
5 |
29 |
0.0008546 |
0.003013 |
1321 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
11 |
135 |
0.0008654 |
0.003046 |
1322 |
FATTY ACID METABOLIC PROCESS |
18 |
296 |
0.0008653 |
0.003046 |
1323 |
REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS |
9 |
95 |
0.0008664 |
0.003047 |
1324 |
DNA METABOLIC PROCESS |
35 |
758 |
0.000898 |
0.003156 |
1325 |
NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
11 |
136 |
0.0009199 |
0.00323 |
1326 |
T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE |
7 |
60 |
0.0009462 |
0.003318 |
1327 |
MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY |
7 |
60 |
0.0009462 |
0.003318 |
1328 |
FEMALE SEX DIFFERENTIATION |
10 |
116 |
0.0009541 |
0.003343 |
1329 |
REGULATION OF DEPHOSPHORYLATION |
12 |
158 |
0.0009549 |
0.003343 |
1330 |
HINDBRAIN DEVELOPMENT |
11 |
137 |
0.0009771 |
0.003418 |
1331 |
POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION |
5 |
30 |
0.001004 |
0.003493 |
1332 |
MEMBRANE BIOGENESIS |
5 |
30 |
0.001004 |
0.003493 |
1333 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE |
5 |
30 |
0.001004 |
0.003493 |
1334 |
BLASTOCYST FORMATION |
5 |
30 |
0.001004 |
0.003493 |
1335 |
BROWN FAT CELL DIFFERENTIATION |
5 |
30 |
0.001004 |
0.003493 |
1336 |
RESPONSE TO ATP |
5 |
30 |
0.001004 |
0.003493 |
1337 |
CELLULAR RESPONSE TO ESTRADIOL STIMULUS |
5 |
30 |
0.001004 |
0.003493 |
1338 |
WNT SIGNALING PATHWAY |
20 |
351 |
0.001025 |
0.003565 |
1339 |
NEGATIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
7 |
61 |
0.001045 |
0.003632 |
1340 |
ATRIAL SEPTUM DEVELOPMENT |
4 |
18 |
0.001064 |
0.003687 |
1341 |
RESPONSE TO CAFFEINE |
4 |
18 |
0.001064 |
0.003687 |
1342 |
KIDNEY MESENCHYME DEVELOPMENT |
4 |
18 |
0.001064 |
0.003687 |
1343 |
POSITIVE REGULATION OF DNA RECOMBINATION |
4 |
18 |
0.001064 |
0.003687 |
1344 |
ENDOTHELIAL CELL DEVELOPMENT |
6 |
45 |
0.001075 |
0.003717 |
1345 |
POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION |
6 |
45 |
0.001075 |
0.003717 |
1346 |
SMOOTH MUSCLE CONTRACTION |
6 |
45 |
0.001075 |
0.003717 |
1347 |
MEMORY |
9 |
98 |
0.001083 |
0.003739 |
1348 |
NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
9 |
98 |
0.001083 |
0.003739 |
1349 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL |
11 |
139 |
0.001101 |
0.003796 |
1350 |
FC RECEPTOR SIGNALING PATHWAY |
14 |
206 |
0.001113 |
0.003835 |
1351 |
BLASTOCYST DEVELOPMENT |
7 |
62 |
0.001152 |
0.003968 |
1352 |
GLUCOSE METABOLIC PROCESS |
10 |
119 |
0.001161 |
0.003996 |
1353 |
DNA DEPENDENT DNA REPLICATION |
9 |
99 |
0.001164 |
0.004001 |
1354 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
9 |
99 |
0.001164 |
0.004001 |
1355 |
CARDIAC ATRIUM DEVELOPMENT |
5 |
31 |
0.001171 |
0.004007 |
1356 |
REGULATION OF MICROTUBULE POLYMERIZATION |
5 |
31 |
0.001171 |
0.004007 |
1357 |
NEURON FATE SPECIFICATION |
5 |
31 |
0.001171 |
0.004007 |
1358 |
POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION |
5 |
31 |
0.001171 |
0.004007 |
1359 |
MISMATCH REPAIR |
5 |
31 |
0.001171 |
0.004007 |
1360 |
REGULATION OF PLATELET ACTIVATION |
5 |
31 |
0.001171 |
0.004007 |
1361 |
ICOSANOID BIOSYNTHETIC PROCESS |
6 |
46 |
0.00121 |
0.004126 |
1362 |
CEREBELLAR CORTEX DEVELOPMENT |
6 |
46 |
0.00121 |
0.004126 |
1363 |
REGULATION OF ALPHA BETA T CELL DIFFERENTIATION |
6 |
46 |
0.00121 |
0.004126 |
1364 |
FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS |
6 |
46 |
0.00121 |
0.004126 |
1365 |
DNA REPLICATION |
14 |
208 |
0.001221 |
0.004161 |
1366 |
NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
7 |
63 |
0.001267 |
0.004317 |
1367 |
REGULATION OF PEPTIDE SECRETION |
14 |
209 |
0.001278 |
0.004349 |
1368 |
PROSTAGLANDIN BIOSYNTHETIC PROCESS |
4 |
19 |
0.00132 |
0.004448 |
1369 |
NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION |
4 |
19 |
0.00132 |
0.004448 |
1370 |
THYMIC T CELL SELECTION |
4 |
19 |
0.00132 |
0.004448 |
1371 |
CELLULAR RESPONSE TO FLUID SHEAR STRESS |
4 |
19 |
0.00132 |
0.004448 |
1372 |
DEFENSE RESPONSE TO VIRUS |
12 |
164 |
0.001319 |
0.004448 |
1373 |
REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION |
4 |
19 |
0.00132 |
0.004448 |
1374 |
NEGATIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS |
4 |
19 |
0.00132 |
0.004448 |
1375 |
NEGATIVE REGULATION OF ATP METABOLIC PROCESS |
4 |
19 |
0.00132 |
0.004448 |
1376 |
ENTEROENDOCRINE CELL DIFFERENTIATION |
4 |
19 |
0.00132 |
0.004448 |
1377 |
CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS |
4 |
19 |
0.00132 |
0.004448 |
1378 |
ERROR PRONE TRANSLESION SYNTHESIS |
4 |
19 |
0.00132 |
0.004448 |
1379 |
MUSCLE CELL CELLULAR HOMEOSTASIS |
4 |
19 |
0.00132 |
0.004448 |
1380 |
PROSTANOID BIOSYNTHETIC PROCESS |
4 |
19 |
0.00132 |
0.004448 |
1381 |
ASTROCYTE DEVELOPMENT |
4 |
19 |
0.00132 |
0.004448 |
1382 |
MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY |
5 |
32 |
0.001359 |
0.004557 |
1383 |
BLOOD VESSEL REMODELING |
5 |
32 |
0.001359 |
0.004557 |
1384 |
NEGATIVE REGULATION OF T CELL DIFFERENTIATION |
5 |
32 |
0.001359 |
0.004557 |
1385 |
NEURON DEATH |
6 |
47 |
0.001356 |
0.004557 |
1386 |
POSITIVE REGULATION OF DEPHOSPHORYLATION |
6 |
47 |
0.001356 |
0.004557 |
1387 |
REGULATION OF NEUTROPHIL MIGRATION |
5 |
32 |
0.001359 |
0.004557 |
1388 |
NEGATIVE REGULATION OF TRANSPORTER ACTIVITY |
7 |
64 |
0.001391 |
0.004661 |
1389 |
REGULATION OF PROTEIN ACETYLATION |
7 |
64 |
0.001391 |
0.004661 |
1390 |
MICROTUBULE BASED PROCESS |
26 |
522 |
0.001422 |
0.004761 |
1391 |
MITOTIC NUCLEAR DIVISION |
20 |
361 |
0.001437 |
0.004806 |
1392 |
OXIDATION REDUCTION PROCESS |
39 |
898 |
0.001455 |
0.004862 |
1393 |
ESTABLISHMENT OF LOCALIZATION IN CELL |
64 |
1676 |
0.001464 |
0.00489 |
1394 |
RESPONSE TO FATTY ACID |
8 |
83 |
0.001485 |
0.004955 |
1395 |
RESPONSE TO AXON INJURY |
6 |
48 |
0.001516 |
0.005044 |
1396 |
NEGATIVE REGULATION OF COAGULATION |
6 |
48 |
0.001516 |
0.005044 |
1397 |
REGULATION OF LIPID KINASE ACTIVITY |
6 |
48 |
0.001516 |
0.005044 |
1398 |
DIGESTIVE TRACT MORPHOGENESIS |
6 |
48 |
0.001516 |
0.005044 |
1399 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT |
6 |
48 |
0.001516 |
0.005044 |
1400 |
PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE |
7 |
65 |
0.001525 |
0.005068 |
1401 |
ANTIGEN PROCESSING AND PRESENTATION |
14 |
213 |
0.001529 |
0.005077 |
1402 |
POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS |
5 |
33 |
0.001567 |
0.005193 |
1403 |
EMBRYONIC EYE MORPHOGENESIS |
5 |
33 |
0.001567 |
0.005193 |
1404 |
G2 DNA DAMAGE CHECKPOINT |
5 |
33 |
0.001567 |
0.005193 |
1405 |
CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION |
4 |
20 |
0.001616 |
0.005311 |
1406 |
NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
4 |
20 |
0.001616 |
0.005311 |
1407 |
NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY |
4 |
20 |
0.001616 |
0.005311 |
1408 |
ESTABLISHMENT OF MITOTIC SPINDLE ORIENTATION |
4 |
20 |
0.001616 |
0.005311 |
1409 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
8 |
84 |
0.001604 |
0.005311 |
1410 |
CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS |
4 |
20 |
0.001616 |
0.005311 |
1411 |
TELENCEPHALON GLIAL CELL MIGRATION |
4 |
20 |
0.001616 |
0.005311 |
1412 |
ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS |
4 |
20 |
0.001616 |
0.005311 |
1413 |
MEGAKARYOCYTE DIFFERENTIATION |
4 |
20 |
0.001616 |
0.005311 |
1414 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN |
4 |
20 |
0.001616 |
0.005311 |
1415 |
BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS |
4 |
20 |
0.001616 |
0.005311 |
1416 |
RESPONSE TO LEAD ION |
4 |
20 |
0.001616 |
0.005311 |
1417 |
CELLULAR RESPONSE TO UV |
7 |
66 |
0.001668 |
0.005473 |
1418 |
LENS DEVELOPMENT IN CAMERA TYPE EYE |
7 |
66 |
0.001668 |
0.005473 |
1419 |
STEROID HORMONE MEDIATED SIGNALING PATHWAY |
10 |
125 |
0.001685 |
0.005524 |
1420 |
REGULATION OF NUCLEOSIDE METABOLIC PROCESS |
6 |
49 |
0.00169 |
0.005535 |
1421 |
REGULATION OF ATP METABOLIC PROCESS |
6 |
49 |
0.00169 |
0.005535 |
1422 |
CARDIAC SEPTUM DEVELOPMENT |
8 |
85 |
0.001731 |
0.005664 |
1423 |
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
5 |
34 |
0.001798 |
0.005868 |
1424 |
CD4 POSITIVE ALPHA BETA T CELL ACTIVATION |
5 |
34 |
0.001798 |
0.005868 |
1425 |
ER NUCLEUS SIGNALING PATHWAY |
5 |
34 |
0.001798 |
0.005868 |
1426 |
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE |
5 |
34 |
0.001798 |
0.005868 |
1427 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
7 |
67 |
0.001821 |
0.00593 |
1428 |
REGULATION OF NOTCH SIGNALING PATHWAY |
7 |
67 |
0.001821 |
0.00593 |
1429 |
REGULATION OF PROTEIN COMPLEX DISASSEMBLY |
14 |
217 |
0.00182 |
0.00593 |
1430 |
FACE DEVELOPMENT |
6 |
50 |
0.001879 |
0.006115 |
1431 |
METANEPHRIC NEPHRON MORPHOGENESIS |
4 |
21 |
0.001956 |
0.006319 |
1432 |
NECROPTOTIC PROCESS |
4 |
21 |
0.001956 |
0.006319 |
1433 |
REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION |
4 |
21 |
0.001956 |
0.006319 |
1434 |
CHONDROCYTE DEVELOPMENT |
4 |
21 |
0.001956 |
0.006319 |
1435 |
DECIDUALIZATION |
4 |
21 |
0.001956 |
0.006319 |
1436 |
POSITIVE T CELL SELECTION |
4 |
21 |
0.001956 |
0.006319 |
1437 |
VIRAL GENOME REPLICATION |
4 |
21 |
0.001956 |
0.006319 |
1438 |
REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS |
4 |
21 |
0.001956 |
0.006319 |
1439 |
NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
4 |
21 |
0.001956 |
0.006319 |
1440 |
NEGATIVE REGULATION OF PROTEIN ACETYLATION |
4 |
21 |
0.001956 |
0.006319 |
1441 |
ORGAN GROWTH |
7 |
68 |
0.001985 |
0.006406 |
1442 |
NERVE DEVELOPMENT |
7 |
68 |
0.001985 |
0.006406 |
1443 |
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS |
8 |
87 |
0.002009 |
0.006477 |
1444 |
NADH METABOLIC PROCESS |
5 |
35 |
0.002053 |
0.006603 |
1445 |
MEMBRANE PROTEIN PROTEOLYSIS |
5 |
35 |
0.002053 |
0.006603 |
1446 |
RESPONSE TO MONOAMINE |
5 |
35 |
0.002053 |
0.006603 |
1447 |
REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES |
5 |
35 |
0.002053 |
0.006603 |
1448 |
REGULATION OF CELLULAR KETONE METABOLIC PROCESS |
12 |
173 |
0.002073 |
0.006662 |
1449 |
NEURAL CREST CELL MIGRATION |
6 |
51 |
0.002083 |
0.006686 |
1450 |
REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
6 |
51 |
0.002083 |
0.006686 |
1451 |
NUCLEAR IMPORT |
10 |
129 |
0.00213 |
0.00682 |
1452 |
CELL JUNCTION ASSEMBLY |
10 |
129 |
0.00213 |
0.00682 |
1453 |
REGULATION OF CAMP METABOLIC PROCESS |
10 |
129 |
0.00213 |
0.00682 |
1454 |
NEGATIVE REGULATION OF MULTI ORGANISM PROCESS |
11 |
151 |
0.002139 |
0.006846 |
1455 |
REGULATION OF HEART CONTRACTION |
14 |
221 |
0.002156 |
0.006893 |
1456 |
MICROTUBULE CYTOSKELETON ORGANIZATION |
19 |
348 |
0.002204 |
0.007042 |
1457 |
POSITIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS |
9 |
109 |
0.002281 |
0.007283 |
1458 |
POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
6 |
52 |
0.002304 |
0.007353 |
1459 |
NEGATIVE REGULATION OF MUSCLE CONTRACTION |
4 |
22 |
0.002341 |
0.007406 |
1460 |
BONE CELL DEVELOPMENT |
4 |
22 |
0.002341 |
0.007406 |
1461 |
SEX DETERMINATION |
4 |
22 |
0.002341 |
0.007406 |
1462 |
POSITIVE REGULATION OF PROTEIN OLIGOMERIZATION |
4 |
22 |
0.002341 |
0.007406 |
1463 |
CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
5 |
36 |
0.002334 |
0.007406 |
1464 |
REGULATION OF CELLULAR EXTRAVASATION |
4 |
22 |
0.002341 |
0.007406 |
1465 |
POSITIVE REGULATION OF AXON EXTENSION |
5 |
36 |
0.002334 |
0.007406 |
1466 |
REGULATION OF T CELL CYTOKINE PRODUCTION |
4 |
22 |
0.002341 |
0.007406 |
1467 |
TOXIN TRANSPORT |
5 |
36 |
0.002334 |
0.007406 |
1468 |
NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT |
5 |
36 |
0.002334 |
0.007406 |
1469 |
POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
5 |
36 |
0.002334 |
0.007406 |
1470 |
EMBRYONIC PLACENTA MORPHOGENESIS |
4 |
22 |
0.002341 |
0.007406 |
1471 |
HISTONE H3 DEACETYLATION |
4 |
22 |
0.002341 |
0.007406 |
1472 |
MUSCLE ORGAN MORPHOGENESIS |
7 |
70 |
0.002348 |
0.007421 |
1473 |
MALE GAMETE GENERATION |
24 |
486 |
0.002386 |
0.007533 |
1474 |
RETINA DEVELOPMENT IN CAMERA TYPE EYE |
10 |
131 |
0.002385 |
0.007533 |
1475 |
REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
16 |
274 |
0.002472 |
0.007798 |
1476 |
URETER DEVELOPMENT |
3 |
11 |
0.002522 |
0.007828 |
1477 |
REGULATION OF CHOLESTEROL HOMEOSTASIS |
3 |
11 |
0.002522 |
0.007828 |
1478 |
NEGATIVE REGULATION OF SODIUM ION TRANSPORT |
3 |
11 |
0.002522 |
0.007828 |
1479 |
NEGATIVE REGULATION OF GLYCOLYTIC PROCESS |
3 |
11 |
0.002522 |
0.007828 |
1480 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE |
3 |
11 |
0.002522 |
0.007828 |
1481 |
VENTRAL SPINAL CORD INTERNEURON SPECIFICATION |
3 |
11 |
0.002522 |
0.007828 |
1482 |
RESPONSE TO GRAVITY |
3 |
11 |
0.002522 |
0.007828 |
1483 |
REGULATION OF T HELPER 2 CELL DIFFERENTIATION |
3 |
11 |
0.002522 |
0.007828 |
1484 |
POSITIVE REGULATION OF CELL DIVISION |
10 |
132 |
0.002522 |
0.007828 |
1485 |
REGULATION OF CHRONIC INFLAMMATORY RESPONSE |
3 |
11 |
0.002522 |
0.007828 |
1486 |
MUSCLE ATROPHY |
3 |
11 |
0.002522 |
0.007828 |
1487 |
SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT |
3 |
11 |
0.002522 |
0.007828 |
1488 |
REGULATION OF PHOSPHOLIPASE A2 ACTIVITY |
3 |
11 |
0.002522 |
0.007828 |
1489 |
BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS |
3 |
11 |
0.002522 |
0.007828 |
1490 |
CYCLOOXYGENASE PATHWAY |
3 |
11 |
0.002522 |
0.007828 |
1491 |
NEGATIVE REGULATION OF CELLULAR SENESCENCE |
3 |
11 |
0.002522 |
0.007828 |
1492 |
NEGATIVE REGULATION OF COENZYME METABOLIC PROCESS |
3 |
11 |
0.002522 |
0.007828 |
1493 |
POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION |
3 |
11 |
0.002522 |
0.007828 |
1494 |
NEGATIVE REGULATION OF COFACTOR METABOLIC PROCESS |
3 |
11 |
0.002522 |
0.007828 |
1495 |
REGULATION OF INTERFERON GAMMA SECRETION |
3 |
11 |
0.002522 |
0.007828 |
1496 |
CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION |
3 |
11 |
0.002522 |
0.007828 |
1497 |
VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS |
3 |
11 |
0.002522 |
0.007828 |
1498 |
NEGATIVE REGULATION OF NECROTIC CELL DEATH |
3 |
11 |
0.002522 |
0.007828 |
1499 |
RESPONSE TO STARVATION |
11 |
154 |
0.002496 |
0.007828 |
1500 |
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY |
6 |
53 |
0.002542 |
0.007879 |
1501 |
NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
6 |
53 |
0.002542 |
0.007879 |
1502 |
CELL FATE SPECIFICATION |
7 |
71 |
0.002547 |
0.00789 |
1503 |
POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS |
9 |
111 |
0.002582 |
0.007988 |
1504 |
NEGATIVE REGULATION OF DNA METABOLIC PROCESS |
9 |
111 |
0.002582 |
0.007988 |
1505 |
SENSORY PERCEPTION OF MECHANICAL STIMULUS |
11 |
155 |
0.002625 |
0.00811 |
1506 |
REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS |
11 |
155 |
0.002625 |
0.00811 |
1507 |
CELLULAR RESPONSE TO LIGHT STIMULUS |
8 |
91 |
0.002668 |
0.008239 |
1508 |
ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT |
4 |
23 |
0.002776 |
0.008515 |
1509 |
POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION |
4 |
23 |
0.002776 |
0.008515 |
1510 |
CRANIAL NERVE MORPHOGENESIS |
4 |
23 |
0.002776 |
0.008515 |
1511 |
REGULATION OF OSTEOBLAST PROLIFERATION |
4 |
23 |
0.002776 |
0.008515 |
1512 |
EPIBOLY |
4 |
23 |
0.002776 |
0.008515 |
1513 |
ACTIN FILAMENT POLYMERIZATION |
4 |
23 |
0.002776 |
0.008515 |
1514 |
TRABECULA FORMATION |
4 |
23 |
0.002776 |
0.008515 |
1515 |
STRIATED MUSCLE ADAPTATION |
4 |
23 |
0.002776 |
0.008515 |
1516 |
POSITIVE REGULATION OF STEROID METABOLIC PROCESS |
4 |
23 |
0.002776 |
0.008515 |
1517 |
REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER |
4 |
23 |
0.002776 |
0.008515 |
1518 |
POSTREPLICATION REPAIR |
6 |
54 |
0.002797 |
0.008563 |
1519 |
MONOSACCHARIDE TRANSPORT |
6 |
54 |
0.002797 |
0.008563 |
1520 |
REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL |
6 |
54 |
0.002797 |
0.008563 |
1521 |
HEXOSE METABOLIC PROCESS |
11 |
157 |
0.002899 |
0.008869 |
1522 |
PROTEIN CATABOLIC PROCESS |
27 |
579 |
0.002938 |
0.008982 |
1523 |
SINGLE ORGANISM BIOSYNTHETIC PROCESS |
52 |
1340 |
0.00295 |
0.009012 |
1524 |
REGULATION OF DOUBLE STRAND BREAK REPAIR |
5 |
38 |
0.002977 |
0.009054 |
1525 |
SPINDLE LOCALIZATION |
5 |
38 |
0.002977 |
0.009054 |
1526 |
POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING |
5 |
38 |
0.002977 |
0.009054 |
1527 |
REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION |
5 |
38 |
0.002977 |
0.009054 |
1528 |
CYTOKINE SECRETION |
5 |
38 |
0.002977 |
0.009054 |
1529 |
CELL GROWTH |
10 |
135 |
0.00297 |
0.009054 |
1530 |
REGULATION OF LYMPHOCYTE MIGRATION |
5 |
38 |
0.002977 |
0.009054 |
1531 |
EMBRYONIC HEART TUBE DEVELOPMENT |
7 |
73 |
0.002984 |
0.009063 |
1532 |
G1 DNA DAMAGE CHECKPOINT |
7 |
73 |
0.002984 |
0.009063 |
1533 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
9 |
114 |
0.003093 |
0.009387 |
1534 |
TOLERANCE INDUCTION |
3 |
12 |
0.003297 |
0.009842 |
1535 |
CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS |
4 |
24 |
0.003263 |
0.009842 |
1536 |
REGULATION OF TIMING OF CELL DIFFERENTIATION |
3 |
12 |
0.003297 |
0.009842 |
1537 |
POSITIVE REGULATION OF THYMOCYTE AGGREGATION |
3 |
12 |
0.003297 |
0.009842 |
1538 |
NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS |
3 |
12 |
0.003297 |
0.009842 |
1539 |
CELLULAR RESPONSE TO ATP |
3 |
12 |
0.003297 |
0.009842 |
1540 |
NEGATIVE REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS |
3 |
12 |
0.003297 |
0.009842 |
1541 |
EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS |
4 |
24 |
0.003263 |
0.009842 |
1542 |
REGULATION OF CHEMOKINE SECRETION |
3 |
12 |
0.003297 |
0.009842 |
1543 |
RESPONSE TO STEROL |
4 |
24 |
0.003263 |
0.009842 |
1544 |
POST EMBRYONIC MORPHOGENESIS |
3 |
12 |
0.003297 |
0.009842 |
1545 |
SPINAL CORD PATTERNING |
4 |
24 |
0.003263 |
0.009842 |
1546 |
REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS |
3 |
12 |
0.003297 |
0.009842 |
1547 |
PERK MEDIATED UNFOLDED PROTEIN RESPONSE |
3 |
12 |
0.003297 |
0.009842 |
1548 |
I KAPPAB PHOSPHORYLATION |
3 |
12 |
0.003297 |
0.009842 |
1549 |
REGULATION OF DNA BIOSYNTHETIC PROCESS |
8 |
94 |
0.003266 |
0.009842 |
1550 |
REGULATION OF DEVELOPMENT HETEROCHRONIC |
3 |
12 |
0.003297 |
0.009842 |
1551 |
POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS |
3 |
12 |
0.003297 |
0.009842 |
1552 |
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION |
4 |
24 |
0.003263 |
0.009842 |
1553 |
CELL ADHESION MEDIATED BY INTEGRIN |
3 |
12 |
0.003297 |
0.009842 |
1554 |
RENAL ABSORPTION |
3 |
12 |
0.003297 |
0.009842 |
1555 |
ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION |
4 |
24 |
0.003263 |
0.009842 |
1556 |
ORGANELLE LOCALIZATION |
21 |
415 |
0.003283 |
0.009842 |
1557 |
ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY |
3 |
12 |
0.003297 |
0.009842 |
1558 |
REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY |
3 |
12 |
0.003297 |
0.009842 |
1559 |
REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION |
3 |
12 |
0.003297 |
0.009842 |
1560 |
ATP GENERATION FROM ADP |
5 |
39 |
0.003343 |
0.009951 |
1561 |
ERBB2 SIGNALING PATHWAY |
5 |
39 |
0.003343 |
0.009951 |
1562 |
EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS |
5 |
39 |
0.003343 |
0.009951 |
1563 |
COCHLEA DEVELOPMENT |
5 |
39 |
0.003343 |
0.009951 |
1564 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
14 |
232 |
0.003351 |
0.00997 |